<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:LFAC="http://lfcapital.com/20220331">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_LFAC_lfcapital.com_20220331 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20220101_20220331 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001851266 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_12/31 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DDocumentFiscalYearFocus_2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DDocumentFiscalPeriodFocus_Q1 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityCentralIndexKey">0001851266</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate">12/31</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:DocumentFiscalPeriodFocus">Q1</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:TaxesPayableCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0089" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-03-31" id="xdx2ixbrl0121" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" id="xdx2ixbrl0122" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0156" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0158" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-03-31" id="xdx2ixbrl0180" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" id="xdx2ixbrl0181" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="LFAC:FranchiseTax" contextRef="From2021-02-192021-03-31" id="xdx2ixbrl0199" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2021-02-192021-03-31" id="xdx2ixbrl0208" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2021-02-192021-03-31" id="xdx2ixbrl0211" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-02-192021-03-31" id="xdx2ixbrl0217" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="LFAC:WeightedAverageSharesOutstandingRedeemableClassACommonStock" contextRef="From2021-02-192021-03-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0224" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="LFAC:BasicAndDilutedNetIncomePerShareRedeemableClassACommonStock" contextRef="From2021-02-192021-03-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0228" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember455426812" id="xdx2ixbrl0238" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0240" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember455426812" id="xdx2ixbrl0244" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_ClassACommonStockMember" id="xdx2ixbrl0248" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_ClassBCommonStockMember" id="xdx2ixbrl0249" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0250" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_custom_ClassACommonStockMember455426828" id="xdx2ixbrl0254" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0256" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_custom_ClassACommonStockMember455426828" id="xdx2ixbrl0260" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-18_custom_ClassACommonStockMember" id="xdx2ixbrl0264" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-18_custom_ClassBCommonStockMember" id="xdx2ixbrl0265" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-18_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0266" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-18_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0267" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-18" id="xdx2ixbrl0268" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-02-18_custom_ClassACommonStockMember" id="xdx2ixbrl0270" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-02-18_custom_ClassBCommonStockMember" id="xdx2ixbrl0272" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-02-192021-03-31_custom_ClassACommonStockMember" id="xdx2ixbrl0282" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-02-192021-03-31_custom_ClassBCommonStockMember" id="xdx2ixbrl0283" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-02-192021-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0284" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_custom_ClassACommonStockMember" id="xdx2ixbrl0288" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_custom_ClassACommonStockMember" id="xdx2ixbrl0294" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredOtherTaxExpenseBenefit" contextRef="From2021-02-192021-03-31" id="xdx2ixbrl0308" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2021-02-192021-03-31" id="xdx2ixbrl0311" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredCharges" contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0316" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredCharges" contextRef="From2021-02-192021-03-31" id="xdx2ixbrl0317" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2021-02-192021-03-31" id="xdx2ixbrl0320" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="LFAC:IncreaseDecreaseInFranchiseTaxPayable" contextRef="From2021-02-192021-03-31" id="xdx2ixbrl0326" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInIncomeTaxes" contextRef="From2021-02-192021-03-31" id="xdx2ixbrl0329" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0340" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromContributionsFromParent" contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0343" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-01to2022-03-31" id="xdx2ixbrl0346" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-02-18" id="xdx2ixbrl0353" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2022-03-31" id="xdx2ixbrl0454" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2021-12-31" id="xdx2ixbrl0462" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="LFAC:AllocationOfNetLoss" contextRef="From2021-02-192021-03-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0551" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-02-192021-03-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0555" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="LFAC:WeightedAverageSharesOutstanding" contextRef="From2021-02-192021-03-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0559" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="LFAC:BasicAndDilutionNetIncomeLossPerShare" contextRef="From2021-02-192021-03-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0563" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextRef="AsOf2022-03-31_us-gaap_FairValueInputsLevel2Member_us-gaap_USTreasurySecuritiesMember" id="xdx2ixbrl0703" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextRef="AsOf2022-03-31_us-gaap_FairValueInputsLevel3Member_us-gaap_USTreasurySecuritiesMember" id="xdx2ixbrl0705" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_USTreasurySecuritiesMember" id="xdx2ixbrl0707" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_USTreasurySecuritiesMember" id="xdx2ixbrl0708" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="lfac-20220331.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-01to2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_UnitsEachConsistingOfOneShareOfClassCommonStockAndOnehalfOfOneRedeemableWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFAC:UnitsEachConsistingOfOneShareOfClassCommonStockAndOnehalfOfOneRedeemableWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_ClassCommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFAC:ClassCommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFAC:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-11_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFAC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-11_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFAC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFAC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFAC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFAC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFAC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-192021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-19</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-192021-03-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-19</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-192021-03-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-19</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ClassACommonStockMember455426812">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFAC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ClassBCommonStockMember455426812">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFAC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-18_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFAC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-18_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFAC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-18_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-18_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFAC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFAC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-192021-03-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFAC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-19</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-192021-03-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFAC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-19</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-192021-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-19</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-192021-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-19</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_ClassACommonStockMember455426828">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFAC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_ClassBCommonStockMember455426828">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFAC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFAC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFAC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-19_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-19_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-19_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-19_us-gaap_PrivatePlacementMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-19_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-19_custom_PrivatePlacementWarrantsMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">LFAC:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-19_custom_UnderwriterMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFAC:UnderwriterMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-19_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFAC:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-19_custom_PublicAndPrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">LFAC:PublicAndPrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-19_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">LFAC:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-19_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">LFAC:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-19_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-032021-11-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-03</xbrli:startDate>
        <xbrli:endDate>2021-11-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-192021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-19</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_ClassBCommonStockMember455428828">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFAC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-192021-03-31_custom_ClassBCommonStockMember455428828">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFAC:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-19</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012021-03-05_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012021-03-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-012021-06-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-21_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFAC:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012021-10-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2021-10-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-26_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFAC:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012021-10-26_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFAC:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2021-10-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-19_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">LFAC:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">LFAC:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-19_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-05_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-18_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_UnderwritingAgreementMember_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">LFAC:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-022021-11-19_custom_UnderwritingAgreementMember_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">LFAC:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-02</xbrli:startDate>
        <xbrli:endDate>2021-11-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_UnderwritingAgreementMember_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">LFAC:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_UnderwritingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">LFAC:UnderwritingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFAC:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFAC:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember455430234">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFAC:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFAC:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_FairValueInputsLevel1Member_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_FairValueInputsLevel2Member_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_FairValueInputsLevel3Member_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM&#160;<span id="xdx_90A_edei--DocumentType_c20220101__20220331_zODsXj3i4h64"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif">(Mark
One)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b><span id="xdx_905_edei--DocumentQuarterlyReport_c20220101__20220331_z9P50S0Xz2Yh"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric></span>
QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif"><b>For
the quarterly period ended <span id="xdx_90C_edei--DocumentPeriodEndDate_c20220101__20220331_zOZxn7axamdg"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March 31, 2022</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b><span id="xdx_901_edei--DocumentTransitionReport_c20220101__20220331_zZjmWBNwOsIc"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span>
TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</b></span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif"><b>For
the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
File No. </b></span><b><span style="font-family: Times New Roman, Times, Serif; background-color: white"><span id="xdx_902_edei--EntityFileNumber_c20220101__20220331_z0XRdCxLuZ97"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityFileNumber">001-41071</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><b><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></b></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0cm; width: 100%"><span style="font: 24pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityRegistrantName_c20220101__20220331_zgjaxAZE7Qad"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityRegistrantName">LF Capital Acquisition Corp. II</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0cm"><span style="font: 10pt Times New Roman, Times, Serif">(Exact name of registrant as specified in its charter)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span>&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="border-bottom: black 1pt solid; padding: 0pt; text-align: center; text-indent: 0pt; width: 50%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20220101__20220331_zi462KiuuFRg"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
<td style="padding: 0pt; text-align: center; text-indent: 0pt; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: black 1pt solid; padding: 0pt; text-align: center; text-indent: 0pt; width: 48%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20220101__20220331_zVFvWmMmOVAj"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityTaxIdentificationNumber">86-2195674</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of<br /> incorporation or organization)</span></td>
<td style="padding: 0pt; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer<br /> Identification No.)&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: center; text-indent: 0pt; width: 100%"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span> <span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20220101__20220331_zIRw1znc2teh"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressAddressLine1">1909 Woodall Rodgers Freeway</ix:nonNumeric></span>,&#160;<span id="xdx_90E_edei--EntityAddressAddressLine2_c20220101__20220331_z1M1ljzLzyIe"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressAddressLine2">Suite 500</ix:nonNumeric></span><br /> <span id="xdx_90B_edei--EntityAddressCityOrTown_c20220101__20220331_zlDThahfhPbd"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressCityOrTown">Dallas</ix:nonNumeric></span>,&#160;<span id="xdx_90F_edei--EntityAddressStateOrProvince_c20220101__20220331_zyypq03XRGV2"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressPostalZipCode_c20220101__20220331_zrB1KiaNn0t5"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityAddressPostalZipCode">75201</ix:nonNumeric></span></b></span> <span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: center; text-indent: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">(Address of Principal Executive Offices, including zip code)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: center; text-indent: 0pt; width: 100%"><span style="font: 10pt Times New Roman, Times, Serif"><b>(<span id="xdx_90D_edei--CityAreaCode_c20220101__20220331_zUgWyUkFK1m7"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:CityAreaCode">214</ix:nonNumeric></span>)&#160;<span id="xdx_904_edei--LocalPhoneNumber_c20220101__20220331_zpV2lTahmEV8"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:LocalPhoneNumber">741-6105</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">(Registrant&#8217;s telephone number, including area code)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0cm"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; text-indent: 0pt; width: 100%"><span style="font: 10pt Times New Roman, Times, Serif"><b>N/A</b></span></td></tr>
<tr style="vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">(Former name, former address and former fiscal&#160;year, if changed since last report)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">Securities
registered pursuant to Section&#160;12(b)&#160;of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="background-color: #CCEEFF">
<td style="padding: 0pt; vertical-align: bottom; text-align: center; text-indent: 0pt; width: 42%"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_edei--Security12bTitle_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneShareOfClassCommonStockAndOnehalfOfOneRedeemableWarrantMember_zhCgs4YlYq71"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_UnitsEachConsistingOfOneShareOfClassCommonStockAndOnehalfOfOneRedeemableWarrantMember" name="dei:Security12bTitle">Units, each consisting of one share of Class A Common Stock and one-half of one Redeemable Warrant</ix:nonNumeric></span>&#160;</span></td>
<td style="padding: 0pt; vertical-align: top; text-align: center; text-indent: 0pt; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: top; text-align: center; text-indent: 0pt; width: 18%"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--TradingSymbol_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneShareOfClassCommonStockAndOnehalfOfOneRedeemableWarrantMember_zcpxy3L4ORW2"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_UnitsEachConsistingOfOneShareOfClassCommonStockAndOnehalfOfOneRedeemableWarrantMember" name="dei:TradingSymbol">LFACU</ix:nonNumeric></span></span></td>
<td style="padding: 0pt; vertical-align: top; text-align: center; text-indent: 0pt; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: top; text-align: center; text-indent: 0pt; width: 36%"><span style="font: 10pt Times New Roman, Times, Serif">The <span id="xdx_909_edei--SecurityExchangeName_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneShareOfClassCommonStockAndOnehalfOfOneRedeemableWarrantMember_zXk7FKCXNv71"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_UnitsEachConsistingOfOneShareOfClassCommonStockAndOnehalfOfOneRedeemableWarrantMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
<tr>
<td style="padding: 0pt; vertical-align: bottom; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--Security12bTitle_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--ClassCommonStockParValue0.0001PerShareMember_zNgV8XapbPYj"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_ClassCommonStockParValue0.0001PerShareMember" name="dei:Security12bTitle">Class A Common Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
<td style="padding: 0pt; vertical-align: top; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: top; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--TradingSymbol_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--ClassCommonStockParValue0.0001PerShareMember_zNAcZyfrcCF2"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_ClassCommonStockParValue0.0001PerShareMember" name="dei:TradingSymbol">LFAC</ix:nonNumeric></span></span></td>
<td style="padding: 0pt; vertical-align: top; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: top; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">The <span id="xdx_90F_edei--SecurityExchangeName_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--ClassCommonStockParValue0.0001PerShareMember_zzRnCwkLsKlf"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_ClassCommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC </span></td></tr>
<tr style="background-color: #CCEEFF">
<td style="padding: 0pt; vertical-align: bottom; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--Security12bTitle_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember_zpVn22GZHSc1"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember" name="dei:Security12bTitle">Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share</ix:nonNumeric></span></span></td>
<td style="padding: 0pt; vertical-align: top; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: top; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_edei--TradingSymbol_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember_zO3D8O8eosNk"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember" name="dei:TradingSymbol">LFACW</ix:nonNumeric></span></span></td>
<td style="padding: 0pt; vertical-align: top; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: top; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">The <span id="xdx_906_edei--SecurityExchangeName_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember_z3qXOCRtQbZ6"><ix:nonNumeric contextRef="From2022-01-012022-03-31_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC </span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark if the Registrant is a
well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Yes
</span><span style="font-family: Times New Roman, Times, Serif">&#9744;&#160;No&#160;&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
</span><span style="font-family: Times New Roman, Times, Serif">&#9744;&#160;No&#160;&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityCurrentReportingStatus_c20220101__20220331_zqoMP5KpEZ03"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#9746;
No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntityInteractiveDataCurrent_c20220101__20220331_z50PLyjPAhU3"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#9746;
No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="padding: 0pt; width: 41%; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Large accelerated filer</span></td>
<td style="padding: 0pt; width: 4%; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#9744;</span></td>
<td style="padding: 0pt; width: 51%; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Accelerated filer</span></td>
<td style="padding: 0pt; width: 4%; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#9744;</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--EntityFilerCategory_c20220101__20220331_zQWbBoOULllh"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span></span></td>
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#9746;</span></td>
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Smaller reporting company</span></td>
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_edei--EntitySmallBusiness_c20220101__20220331_zTELsHPWNXgl"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
<tr>
<td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Emerging growth company</span></td>
<td style="padding: 0pt; vertical-align: top; text-align: justify; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20220101__20220331_zO6zlCFdAUe1"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act&#160;</span><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--EntityExTransitionPeriod_c20220101__20220331_zFr3hAl6L7u4"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the Registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. </span><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;</span><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--EntityShellCompany_c20220101__20220331_zFA5qmX8Mk75"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt:booleantrue" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Registrant&#8217;s shares were not listed on any exchange and had no value as of the last business day of the second fiscal quarter of
2021. The Registrant&#8217;s units began trading on The Nasdaq Global Market (&#8220;Nasdaq&#8221;) on November 17, 2021. The Registrant&#8217;s
shares of Class A Common Stock and warrants began separate trading on Nasdaq on January 7, 2022. The aggregate market value of the units
outstanding, other than shares held by persons who may be deemed affiliates of the Registrant, computed by reference to the closing price
for the units on December 31, 2021, as reported on Nasdaq was $10.02.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of May 11, 2022, there were&#160;<span id="xdx_90E_edei--EntityCommonStockSharesOutstanding_iI_c20220511__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zLyIFq4YDZs4" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-05-11_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,875,000</ix:nonFraction></span>&#160;shares of the Registrant&#8217;s Class A Common Stock, par value $0.0001 per share
(&#8220;Class A Common Stock&#8221;) and&#160;<span id="xdx_909_edei--EntityCommonStockSharesOutstanding_iI_c20220511__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_zki4x95q7SYj" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-05-11_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,468,750</ix:nonFraction></span>&#160;shares of the Registrant&#8217;s Class B Common Stock, par value $0.0001
per share (&#8220;Class B Common Stock&#8221;) issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>LF CAPITAL ACQUISITION CORP. II</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Quarterly Report on Form 10-Q</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>TABLE OF CONTENTS</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b>&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; width: 9%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: top; width: 81%; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 0.25pt; padding-left: 0.25pt; text-align: center; width: 10%"><span style="font: 10pt Times New Roman, Times, Serif">Page</span></td></tr>
<tr style="background-color: #CCEEFF">
<td colspan="2" style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>PART 1 &#8211; FINANCIAL INFORMATION</b></span></td>
<td style="text-align: right; vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="background-color: transparent">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">Item 1.</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_001">Interim Financial Statements (Unaudited)</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;1</span></td></tr>
<tr style="background-color: #CCEEFF">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_002">Unaudited Condensed Balance Sheets as of March 31, 2022 and December 31,
2021</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;1</span></td></tr>
<tr style="background-color: transparent">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_003">Unaudited Condensed Statements of Operations for the three months ended
March 31, 2022 and for the period February 19, 2021 (inception) to March 31, 2022</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>2</td></tr>
<tr style="background-color: #CCEEFF">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_004">Unaudited Condensed Statements of Changes in Stockholders&#8217; Deficit
for the three months ended March 31, 2022 and for the period February 19, 2021 (inception) to March 31, 2021</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>3</td></tr>
<tr style="background-color: transparent">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_005">Unaudited Condensed Statement of Cash Flows for the three months ended March 31,
2022 and for the period February 19, 2021 (inception) to March 31, 2021</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>4</td></tr>
<tr style="background-color: #CCEEFF">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_006">Notes to Condensed Financial Statement (Unaudited)</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>5</td></tr>
<tr style="background-color: transparent">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">Item 2.</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_007">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>17</td></tr>
<tr style="background-color: #CCEEFF">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">Item 3.</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_008">Quantitative and Qualitative Disclosures about Market Risk</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>19</td></tr>
<tr style="background-color: transparent">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">Item 4.</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_009">Control and Procedures</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>19</td></tr>
<tr style="background-color: #CCEEFF">
<td colspan="2" style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>PART II &#8211; <a href="#a_010">OTHER INFORMATION</a></b></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="background-color: transparent">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">Item 1.</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_011">Legal Proceedings</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>20</td></tr>
<tr style="background-color: #CCEEFF">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">Item 1A.</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_012">Risk Factors</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>20</td></tr>
<tr style="background-color: transparent">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">Item 2.</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_013">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>20</td></tr>
<tr style="background-color: #CCEEFF">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">Item 3.</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_014">Defaults Upon Senior Securities</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>20</td></tr>
<tr style="background-color: transparent">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">Item 4.</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_015">Mine Safety Disclosures</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>21</td></tr>
<tr style="background-color: #CCEEFF">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">Item 5.</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_016">Other Information</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>21</td></tr>
<tr style="background-color: transparent">
<td style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">Item 6.</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_017">Exhibits</a></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>21</td></tr>
<tr style="background-color: #CCEEFF">
<td colspan="2" style="vertical-align: top; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><a href="#a_018">SIGNATURES</a></b></span></td>
<td style="vertical-align: bottom; padding-top: 0.25pt; padding-bottom: 0.25pt; padding-left: 0.25pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span>22</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 3; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b><span id="a_001"></span>Item 1. Interim Financial Statements (Unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; white-space: nowrap; width: 100%; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_002"></span>LF CAPITAL ACQUISITION CORP. II</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; white-space: nowrap; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CONDENSED
BALANCE SHEETS</b></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 100%; margin-top: 3pt; margin-bottom: 3pt" />
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_111_zYbbRHWeqgKl" summary="xdx: Statement - CONDENSED BALANCE SHEETS (UNAUDITED)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_496_20220331" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_499_20211231_zwZ2eZ2xeYQ4" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">March 31, 2022 (Unaudited)</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31, 2021</td></tr>
  <tr id="xdx_401_eus-gaap--AssetsAbstract_iB_zoZMwZ61Vm7e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: center">ASSETS</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetsCurrentAbstract_i01B_zcKWkJzTgrH8" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">CURRENT ASSETS</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Cash_i02I_maACzRoT_zOuoOOCum6Cb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-indent: -10pt">Cash</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,604</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">325,250</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PrepaidExpenseCurrent_i02I_pp0p0_maACzRoT_zLNK5cDihEi8" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Prepaid expenses and other assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">425,501</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">430,477</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsCurrent_i01TI_mtACzRoT_maAzZhy_zu9tWTt2LFPl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-weight: bold; text-align: left; text-indent: -10pt">&#160;Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">497,105</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">755,727</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PrepaidExpenseNoncurrent_i01I_pp0p0_maAzZhy_zaE1zc47ZwPg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Prepaid expenses-non current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseNoncurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">264,131</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">367,039</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredIncomeTaxAssetsNet_i01I_pp0p0_maAzZhy_zjnSQI5M9pY5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,761</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,287</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetsHeldInTrust_i01I_maAzZhy_zQPuLuAjkC3i" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Investments held in Trust Account</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrust" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">264,079,072</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrust" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">263,937,611</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Assets_iTI_mtAzZhy_zSUpksjYwMnh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-weight: bold; text-align: left; text-indent: -10pt">&#160;TOTAL ASSETS</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">264,842,069</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,079,664</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: center">LIABILITIES AND STOCKHOLDERS&#8217; DEFICIT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesCurrentAbstract_i01B_zC2SgTS58f3j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">CURRENT LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i01I_maLCzIbO_z3wsVk2OlvZh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">177,733</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,313</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--FranchiseTaxPayable_i01I_maLCzIbO_zXa9UFnJQSs9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Franchise tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="LFAC:FranchiseTaxPayable" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="LFAC:FranchiseTaxPayable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,842</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--TaxesPayableCurrent_i01I_maLCzIbO_zAlZbO4SFMM5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Income tax payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,381</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0089">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesCurrent_i01TI_mtLCzIbO_maLzv0F_zdCq2WbK0Mh4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-weight: bold; text-align: left; text-indent: -10pt">&#160;Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">232,114</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">152,155</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredUnderwritingFeePayable_i01I_maLzv0F_zRKDIbHM3dbl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Deferred underwriting fee payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="LFAC:DeferredUnderwritingFeePayable" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,056,250</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="LFAC:DeferredUnderwritingFeePayable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,056,250</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Liabilities_i01TI_mtLzv0F_maLASEzknS_zMx9Z5oQfTR4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 1pt 30pt; font-weight: bold; text-align: left; text-indent: -10pt">&#160;Total liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,288,364</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,208,405</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">COMMITMENTS AND CONTINGENCIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_pp0p0_maLASEzknS_zliHIKEJlmXg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class A Common Stock subject to possible redemption, $<span id="xdx_90E_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_c20220331__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_z6S8v2Q3ID26" title="Temporary equity, par value"><span id="xdx_907_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zwCVrsasAMPi" title="Temporary equity, par value"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2022-03-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value, <span id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_c20220331__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zl6fJmyaXoVf" title="Temporary Equity, Shares Issued"><span id="xdx_909_eus-gaap--TemporaryEquitySharesOutstanding_c20220331__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_pdd" title="Temporary equity, shares outstanding"><span id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zfPxZXtNq5Ee" title="Temporary Equity, Shares Issued"><span id="xdx_909_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zUR5xsxSU0K9" title="Temporary Equity, Shares Outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2022-03-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-03-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,875,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding at redemption value of $<span id="xdx_907_eus-gaap--TemporaryEquityRedemptionPricePerShare_c20220331__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_pdd" title="Temporary equity, redemption price per share"><span id="xdx_90C_eus-gaap--TemporaryEquityRedemptionPricePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zCvwxZg2Q9mj"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="AsOf2022-03-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.20</ix:nonFraction></ix:nonFraction></span></span> per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">263,925,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">263,925,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">STOCKHOLDERS&#8217; DEFICIT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PreferredStockValue_i01I_pp0p0_maSEzNW9_zA8Aj7ybJQe6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Preferred stock, $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_c20220331_pdd" title="Preferred stock, par value"><span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211231_zRXeHMz3N2F4" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_c20220331_pdd" title="Preferred Stock, shares authorized"><span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_zO6V5ORzWwU1" title="Preferred Stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_dn_c20220331_zZoc3Wcw8q4d" title="Preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20220331_zoLZrZ3oYIFd" title="Preferred stock, shares outstanding"><span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_dn_c20211231_zprJvDyVTFC2" title="Preferred stock, shares issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20211231_zEjhFLYwHORh" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-03-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-03-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0121">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0122">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Class A Common Stock; $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_c20220331__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_pdd" title="Common stock, par value"><span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zR6uiffFnSah" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_c20220331__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_pdd" title="Common stock, shares authorized"><span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zeWs1afJgdyk" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_dn_c20220331__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_z3P7FwMFTOt4" title="Common stock, shares issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_dn_c20220331__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_z45q5U8XH4vh" title="Common stock, shares outstanding"><span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_dn_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zoJ2ZdA89MF6" title="Common stock, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_dn_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_z6IchqMulTr2" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-03-31_custom_ClassACommonStockMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-03-31_custom_ClassACommonStockMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued or outstanding (excluding 25,875,000 shares subject to possible redemption)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--CommonStockValue_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pp0p0" title="Common stock value" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0156">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--CommonStockValue_iI_pp0p0_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zeRbCq00frG3" title="Common stock value" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0158">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Class B Common Stock; $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_c20220331__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_pdd" title="Common stock, par value"><span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_zI9A79FGM3b1" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_c20220331__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_pdd" title="Common stock, shares authorized"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_zDFMs3aaBYwa" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_c20220331__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_pdd" title="Common stock, shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_c20220331__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_pdd" title="Common stock, shares outstanding"><span id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_z2UIwD5NCEp3" title="Common stock, shares issued"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_zCNoiBlp9fXb" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-03-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-03-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,468,750</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--CommonStockValue_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pp0p0" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">647</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CommonStockValue_iI_pp0p0_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zM43FDIyGOt3" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">647</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AdditionalPaidInCapital_iI_maSEzNW9_zlfDBIydiDO6" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0180">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0181">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_maSEzNW9_zfNX5Oes68Ij" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,371,942</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,054,388</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--StockholdersEquity_iTI_pp0p0_mtSEzNW9_maLASEzknS_zyOBCd3EQcG1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-weight: bold; text-align: left; text-indent: -10pt">&#160;Total stockholders&#8217; deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">8,371,295</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">8,053,741</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_pp0p0_mtLASEzknS_zJKdrBV4FhS1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-weight: bold; text-align: left; text-indent: -10pt">&#160;TOTAL LIABILITIES AND STOCKHOLDERS&#8217; DEFICIT</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">264,842,069</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">265,079,664</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The accompanying notes are an integral part of these unaudited condensed financial statements.</i></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<!-- Field: Page; Sequence: 4; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding: 0pt; white-space: nowrap; width: 100%; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_003"></span>LF CAPITAL ACQUISITION CORP. II</b></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt; white-space: nowrap; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)</b></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 100%; margin-top: 3pt; margin-bottom: 3pt" />
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_113_z2H9ZQPcmOR1" summary="xdx: Statement - CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_497_20220101__20220331_zLrau9A9CEDa" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_491_20210219__20210331_zYb2auGj99Ub" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">For the three months ended March 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">For the period February 19, 2021 (inception) to March 31, 2021</td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingExpensesAbstract_iB_z5pikQ11efR2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">OPERATING EXPENSES</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_pp0p0_msOILzTll_zzvZgxFInqAb" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -10pt">&#160;General and administrative</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">387,107</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-02-192021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,613</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--FranchiseTax_i01_pp0p0_msOILzTll_zuHbQWmHoUEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">&#160;Franchise tax</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="LFAC:FranchiseTax" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0199">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingIncomeLoss_iNT_pp0p0_di_mtOILzTll_maILFCOziva_zHdPqjH1be67" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-weight: bold; text-align: left; text-indent: -10pt">&#160;Loss from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">437,107</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-02-192021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,613</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OtherIncomeAbstract_iB_zE7t41d7IHC" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">OTHER INCOME</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--UnrealizedGainLossOnInvestments_i01_pp0p0_maOIzEp6_zGeMfzZeYUYc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">&#160;Unrealized gain on investments held in Trust Account</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">141,460</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0208">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OtherIncome_iT_pp0p0_mtOIzEp6_maILFCOziva_zqGqB91Itsh7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-weight: bold; text-align: left; text-indent: -10pt">&#160;Total other income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">141,460</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0211">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_maNILzUEV_mtILFCOziva_znK7L4CZhT47" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">LOSS BEFORE PROVISION FOR INCOME TAXES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">295,647</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-02-192021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,613</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_msNILzUEV_zVVDFNT9Q7Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Income tax expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,907</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0217">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProfitLoss_iT_pp0p0_mtNILzUEV_zWGWAcj3r446" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">NET LOSS</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">317,554</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-02-192021-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,613</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-indent: -10pt">&#160;Weighted average shares outstanding of Class A Common Stock</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstandingRedeemableClassACommonStock_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Weighted average shares outstanding, Redeemable Class A common stock" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="LFAC:WeightedAverageSharesOutstandingRedeemableClassACommonStock" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,875,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_ecustom--WeightedAverageSharesOutstandingRedeemableClassACommonStock_c20210219__20210331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zUJkXt0DdJ45" title="Weighted average shares outstanding, Redeemable Class A common stock" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0224">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">&#160;Basic and diluted net income per share, Class A</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--BasicAndDilutedNetIncomePerShareRedeemableClassACommonStock_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted net income per share, Redeemable Class A common stock" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="LFAC:BasicAndDilutedNetIncomePerShareRedeemableClassACommonStock" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--BasicAndDilutedNetIncomePerShareRedeemableClassACommonStock_c20210219__20210331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zRnKE7BrORY1" title="Basic and diluted net income per share, Redeemable Class A common stock" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0228">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-indent: -10pt">&#160;Weighted average shares outstanding of Class B Common Stock</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--WeightedAverageSharesOutstandingClassBCommonStock_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Weighted average shares outstanding, Class B common stock" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="LFAC:WeightedAverageSharesOutstandingClassBCommonStock" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,468,750</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_ecustom--WeightedAverageSharesOutstandingClassBCommonStock_c20210219__20210331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zBXUboQeJB3c" title="Weighted average shares outstanding, Class B common stock" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="LFAC:WeightedAverageSharesOutstandingClassBCommonStock" contextRef="From2021-02-192021-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,468,750</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">&#160;Basic and diluted net loss per share, Class B</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--BasicAndDilutedNetLossPerShareClassBCommonStock_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted net loss per share, Class B common stock" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="LFAC:BasicAndDilutedNetLossPerShareClassBCommonStock" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--BasicAndDilutedNetLossPerShareClassBCommonStock_c20210219__20210331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zC2MgZoKuik2" title="Basic and diluted net loss per share, Class B common stock" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="LFAC:BasicAndDilutedNetLossPerShareClassBCommonStock" contextRef="From2021-02-192021-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The accompanying notes are an integral part of these unaudited condensed financial statements.</i></span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding: 0pt; white-space: nowrap; width: 100%; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_004"></span>LF CAPITAL ACQUISITION CORP. II</b></span> <span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt; white-space: nowrap; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CONDENSED
STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; DEFICIT (UNAUDITED)</b></span> <span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt; white-space: nowrap; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>FOR THE THREE MONTHS ENDED MARCH 31, 2022</b></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_114_zk9f3NNUYRi3" summary="xdx: Statement - CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; DEFICIT (UNAUDITED)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_custom--ClassACommonStockMember_zlw36851NOB8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_custom--ClassBCommonStockMember_zlBGl7e1ssVb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zUaoriQKPCRk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zJeh2Cdk1je4" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B4_zmfRRYq3Ubde" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="15" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center"><b>Additional</b></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center"><b>Total</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class A</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class B</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center"><b>paid-in</b></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center"><b>Accumulated</b></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center"><b>stockholders&#8217;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> capital</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> deficit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> deficit</td></tr>
  <tr id="xdx_439_c20220101__20220331_eus-gaap--StockholdersEquity_iS_z8RRzoJymRR7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 37%; font-weight: bold; text-indent: -10pt">Balance - 12/31/21</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember_zDNSo2TpAm97" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0244">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0238">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__custom--ClassBCommonStockMember_z27Wwti49Zgg" title="Beginning balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_ClassBCommonStockMember455426812" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,468,750</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_ClassBCommonStockMember455426812" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0240">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$&#160;</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,054,388</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,053,741</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: White; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0248">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: White; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0249">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: White; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0250">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left"></td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">317,554</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left"></td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">317,554</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43F_c20220101__20220331_eus-gaap--StockholdersEquity_iE_zli8EixKwNM2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 2.5pt 10pt; font-weight: bold; text-indent: -10pt">Balance - 03/31/22</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember_zv03us00NfOb" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0260">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$&#160;</td><td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0254">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__custom--ClassBCommonStockMember_zdc5bSCa8yda" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_custom_ClassBCommonStockMember455426828" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,468,750</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_custom_ClassBCommonStockMember455426828" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$&#160;</td><td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0256">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">$&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,371,942</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,371,295</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="29" style="font-weight: bold; text-align: center">FOR THE PERIOD FEBRUARY 19, 2021 (INCEPTION) TO MARCH 31, 2021</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="15" style="border-bottom: Black 1pt solid; text-align: center"><b>Common stock</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>Additional</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>Total</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><b>Class A</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><b>Class B</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>paid-in</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>Accumulated</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="text-align: center"><b>stockholders&#8217;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Amount</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Amount</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>capital</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>deficit</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>equity</b></td></tr>
  <tr id="xdx_43B_c20210219__20210331_eus-gaap--StockholdersEquity_iS_zvEbHWBHwKg9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Balance - 02/19/21 (inception)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_c20210219__20210331__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember_zY5FtWIi63I2" title="Beginning balance, shares" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0270">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0264">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_c20210219__20210331__us-gaap--StatementEquityComponentsAxis__custom--ClassBCommonStockMember_zeLcPR90emz3" title="Beginning balance, shares" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0272">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0265">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0266">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0267">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0268">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueNewIssues_iP3us-gaap--SharesOutstanding_zBjpkl7RNEki" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 37%; text-align: left; text-indent: -10pt">Issuance of Common Stock to initial stockholders</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_iP3us-gaap--StockIssuedDuringPeriodValueNewIssues_c20210219__20210331__us-gaap--StatementEquityComponentsAxis__custom--ClassBCommonStockMember_zPFvqtGJNXRd" title="Issuance of Common Stock to initial stockholders, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-02-192021-03-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,468,750</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-02-192021-03-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-02-192021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,353</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-02-192021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_zgUOP5Iazvjl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0282">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0283">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0284">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-02-192021-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,613</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-02-192021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,613</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_438_c20210219__20210331_eus-gaap--StockholdersEquity_iE_z3gvk8XPMpig" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 2.5pt 10pt; text-indent: -10pt">Balance - 03/31/21</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20210219__20210331__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember_zbXSAg1FYI5l" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0294">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$&#160;</td><td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0288">&#8212;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_c20210219__20210331__us-gaap--StatementEquityComponentsAxis__custom--ClassBCommonStockMember_zVkx8UrG8JMi" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,468,750</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,353</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,613</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,387</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 18pt"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 18pt"><i>The accompanying notes are an
integral part of these unaudited condensed financial statements.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 18pt"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 18pt"><i></i></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 18pt"><i>&#160;</i></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding: 0pt; white-space: nowrap; width: 100%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_005"></span>LF CAPITAL ACQUISITION CORP. II</b></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt; white-space: nowrap; text-align: center; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)</b></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 100%; margin-top: 3pt; margin-bottom: 3pt" />
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_304_112_zA3jRDAUjdPe" summary="xdx: Statement - CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="font-weight: bold">&#160;</td>
<td colspan="3" id="xdx_49E_20220101__20220331_zOmcJWmGPUL3" style="font-weight: bold; text-align: center">&#160;</td>
<td style="font-weight: bold">&#160;</td>
<td colspan="3" id="xdx_496_20210219__20210331_zoSUQNBXY2ka" style="font-weight: bold; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="font-weight: bold">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">For the three months ended March 31, 2022</td>
<td style="font-weight: bold">&#160;</td>
<td colspan="3" style="font-weight: bold; text-align: center">For the period February 19, 2021 (inception) to March 31, 2021</td></tr>
<tr id="xdx_40B_eus-gaap--CashFlowOperatingActivitiesLesseeAbstract_iB_z0KZJhJehGal" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">CASH FLOWS FROM OPERATING ACTIVITIES</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ProfitLoss_i01_maNCPBUzyEd_zCiFcYDNIav" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -10pt">Net loss</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">317,554</ix:nonFraction></td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-02-192021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,613</ix:nonFraction></td>
<td style="width: 1%; text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zHgjbUqzLHw3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">Adjustments to reconcile net loss to net cash used in operating activities:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredOtherTaxExpenseBenefit_i02_pp0p0_maNCPBUzyEd_zNOAMJYN9Lx5" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 40pt; text-align: left; text-indent: -10pt">Change in deferred tax asset</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredOtherTaxExpenseBenefit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,526</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0308">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_i02N_pp0p0_di_msNCPBUzyEd_zYfIU2vDYuL8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 40pt; text-align: left; text-indent: -10pt">Unrealized gain on investments held in Trust Account</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">141,460</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0311">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zWkGfOWdjZfi" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">Changes in operating assets and liabilities:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--IncreaseDecreaseInDeferredCharges_i02N_di_msNCPBUzyEd_zToge6mEQkc7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 40pt; text-align: left; text-indent: -10pt">Deferred offering costs</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0316">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0317">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_iN_di_msNCPBUzyEd_zgLLqSB3ZQU" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 40pt; text-align: left; text-indent: -10pt">Prepaid expenses and other assets</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">107,883</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0320">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_maNCPBUzyEd_zUaAR6d7NcU6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 40pt; text-align: left; text-indent: -10pt">Accounts payable and accrued expenses</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,420</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-02-192021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,598</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--IncreaseDecreaseInFranchiseTaxPayable_maNCPBUzyEd_zXwwVZFbjK3a" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 40pt; text-align: left; text-indent: -10pt">Franchise tax payable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="LFAC:IncreaseDecreaseInFranchiseTaxPayable" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">41,842</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0326">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--IncreaseDecreaseInIncomeTaxes_maNCPBUzyEd_zQO7ydyTftvf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 40pt; text-align: left; text-indent: -10pt">Income tax payable</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInIncomeTaxes" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,381</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;<span style="-sec-ix-hidden: xdx2ixbrl0329">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iT_maCzgSC_mtNCPBUzyEd_zdUxtALwwan" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 40pt; font-weight: bold; text-align: left; text-indent: -10pt">Net cash flows used in operating activities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">253,646</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-02-192021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zHcVNNjqBum6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">CASH FLOWS FROM INVESTING ACTIVITIES</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;&#8212;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zROInP6ZuSG7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">CASH FLOWS FROM FINANCING ACTIVITIES</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maNCPBUz7Md_zDwG5L28d0Tl" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 40pt; text-align: left; text-indent: -10pt">Proceeds from issuance of Class B Common Stock to Sponsor</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0340">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-02-192021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ProceedsFromContributionsFromParent_i01_maNCPBUz7Md_zh3C9IAKUin2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 40pt; text-align: left; text-indent: -10pt">Paid in capital</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;<span style="-sec-ix-hidden: xdx2ixbrl0343">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromContributionsFromParent" contextRef="From2021-02-192021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,353</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivities_iT_maCzgSC_mtNCPBUz7Md_zlIbbElSzqnc" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 40pt; font-weight: bold; text-align: left; text-indent: -10pt">Net cash flows provided by financing activities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0346">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-02-192021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_iT_mtCzgSC_ztwxWsVwqjC4" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt">NET CHANGE IN CASH</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">253,646</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-02-192021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,985</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zKoDJaQ9EMU5" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-indent: -10pt">CASH, BEGINNING OF PERIOD</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">325,250</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0353">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zgQ43Yde9E5l" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-indent: -10pt">CASH, END OF PERIOD</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,604</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,985</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The accompanying notes are an integral part of these unaudited condensed financial statements.</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0cm">&#160;</p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>LF
CAPITAL</b></span><b> ACQUISITION CORP. I</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO C<span style="text-transform: uppercase">ONDENSED
FINANCIAL STATEMENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>March&#160;31,&#160;</b></span><b><span style="text-transform: uppercase">2022</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>(UNAUDITED</b></span><b>)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_804_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z2J5LwSWeuBh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 1 &#8211;&#160;<span id="xdx_824_zda5OOFYKpCi">Description of Organization and Business Operations</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">LF Capital Acquisition Corp. II
(the &#8220;Company&#8221;) was incorporated in Delaware on February 19, 2021. The Company is a blank check company formed for the purpose
of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business
combination with one or more businesses or entities (the &#8220;Business Combination&#8221;). The Company has selected December 31 as
its fiscal year end.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company is not limited to a
particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging
growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">As of March 31, 2022, the Company
had not commenced any operations. All activity from February 19, 2021 (inception) through November 19, 2021, relates to the Company&#8217;s
formation and Initial Public Offering (&#8220;IPO&#8221;), which is described below and, since the IPO, the search for a prospective Business
Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the
earliest. The Company will generate non-operating income in the form of interest income earned on investments from the proceeds derived
from the IPO. The registration statement for the Company&#8217;s IPO was declared effective on November 16, 2021. On November 19, 2021,
the Company consummated the IPO and sold&#160;<span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211119__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Sale of units in initial public offering"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-19_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">22,500,000</ix:nonFraction></span>&#160;units (&#8220;Units&#8221;) with each Unit consisting of one share of Class
A Common Stock and one-half of one redeemable warrant to purchase one share of Class A Common Stock at $<span id="xdx_90C_eus-gaap--SharePrice_c20211119__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-11-19_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span>&#160;per share (each, a
&#8220;Public Warrant&#8221;) at $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_c20211119__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Sale of units per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2021-11-19_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span>&#160;per Unit, generating gross proceeds of $<span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20211101__20211119__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Sale of units in initial public offering aggragate amount"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2021-11-012021-11-19_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">225,000,000</ix:nonFraction></span>, which is discussed in Note 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Simultaneously with the closing
of the IPO, the Company consummated the sale of&#160;<span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211119__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zu4A7v6ukNd2" title="Sale of units in initial public offering"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-19_us-gaap_PrivatePlacementMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,000,000</ix:nonFraction></span>&#160;warrants at a price of $1.00&#160;per warrant in a private placement
(&#8220;Private Placement Warrants&#8221;) to the Company&#8217;s sponsor, Level Field Capital II, LLC (the &#8220;Sponsor&#8221;), the
underwriter of the IPO and certain funds and accounts managed by subsidiaries of a strategic investor (the &#8220;anchor investor&#8221;),
generating gross proceeds of $11,000,000&#160;which is described in Note 4.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Simultaneously with the closing
of the IPO, the Company consummated the closing of the sale of&#160;<span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211119__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zh8YCeDojBVk"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-19_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,375,000</ix:nonFraction></span>&#160;additional Units upon receiving notice of the underwriter&#8217;s
election to fully exercise its overallotment option (&#8220;Overallotment Units&#8221;), generating additional gross proceeds of $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20211101__20211119__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zFtXZVSfEGX7" title="Sale of units in initial public offering aggragate amount"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2021-11-012021-11-19_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,750,000</ix:nonFraction></span>.
Simultaneously with the exercise of the overallotment, the Company consummated the Private Placement of an additional&#160;<span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211119__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zAtWS2lXEC28" title="Sale of units in initial public offering"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-19_custom_PrivatePlacementWarrantsMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,350,000</ix:nonFraction></span>&#160;Private
Placement Warrants to the Sponsor and the underwriter, generating gross proceeds of $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20211101__20211119__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwriterMember_zxK5OS18T6A4" title="Sale of stock"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2021-11-012021-11-19_custom_UnderwriterMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,350,000</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Offering costs for the IPO and
the exercise of the underwriter&#8217;s over-allotment option amounted to $<span id="xdx_90A_ecustom--OfferingCosts_c20220101__20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Offering costs"><ix:nonFraction name="LFAC:OfferingCosts" contextRef="From2022-01-012022-03-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,030,508</ix:nonFraction></span>, consisting of $<span id="xdx_903_ecustom--UnderwritingFees_c20220101__20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Underwriting fees"><ix:nonFraction name="LFAC:UnderwritingFees" contextRef="From2022-01-012022-03-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,231,250</ix:nonFraction></span>&#160;of underwriting
fees, of which $<span id="xdx_904_eus-gaap--CommonStockIssuedEmployeeTrustDeferred_iI_pp0p0_c20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zWtxA36bUJC6" title="Deferred and held in the trust account"><ix:nonFraction name="us-gaap:CommonStockIssuedEmployeeTrustDeferred" contextRef="AsOf2022-03-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,056,250</ix:nonFraction></span>&#160;is deferred and held in the Trust Account (defined below) and $<span id="xdx_907_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20220101__20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Other Offering costs"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2022-01-012022-03-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">799,258</ix:nonFraction></span>&#160;of other offering costs. As
described in Note 5, the $<span id="xdx_907_ecustom--DeferredUnderwritingFees_c20220101__20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Deferred underwriting fees"><ix:nonFraction name="LFAC:DeferredUnderwritingFees" contextRef="From2022-01-012022-03-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,056,250</ix:nonFraction></span>&#160;of deferred underwriting fees payable is contingent upon the consummation of a Business Combination
within 15 months from the closing of IPO (or, following the extension of the period of time to complete the initial business combination
up to six times by an additional period of one month each time for a total of up to 21 months), subject to the terms of the underwriting
agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Following the closing of the IPO
and the exercise of the underwriter&#8217;s over-allotment option, $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220101__20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Net proceeds from sale of units"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2022-01-012022-03-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">263,925,000</ix:nonFraction></span>&#160;($<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_c20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Share price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-03-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.20</ix:nonFraction></span>&#160;per Unit) from the net proceeds from
the sale of the Units in the IPO and the Private Placement Warrants were placed in a trust account (&#8220;Trust Account&#8221;) and have
been invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as
amended (the &#8220;Investment Company Act&#8221;), with a maturity of 180 days or less or in any open-ended investment company that holds
itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7
of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii)
the distribution of the Trust Account, as described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company&#8217;s management
has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Warrants,
although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There
is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial
Business Combinations having an aggregate fair market value of at least&#160;<span id="xdx_902_ecustom--PercentageOfFairMarketValue_dp_c20220101__20220331_z6vtxC5wxyH5" title="Percentage of fair market value"><ix:nonFraction name="LFAC:PercentageOfFairMarketValue" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span>% of the assets held in the Trust Account (excluding the
deferred underwriting fees and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial
Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires&#160;<span id="xdx_902_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_c20220331_z12dNgWGB5V2" title="Business combination, percentage of voting securities"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>%
or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it
not to be required to register as an investment company under the Investment Company Act. There is no assurance the Company will be able
to successfully effect a Business Combination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 8 -->
    <div id="xdx_23C_zpNHGIZRFB3k" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_238_zboD6gnRui4g" style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div id="xdx_232_z7aOaSVUlMZ" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zDtYZY91hi7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company will provide the holders
of the outstanding Public Shares (the &#8220;Public Stockholders&#8221;) with the opportunity to redeem all or a portion of their Public
Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business
Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination
or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro
rata portion of the amount then in the Trust Account (initially anticipated to be $10.20 per Public Share, plus any pro rata interest
then in the Trust Account, net of taxes payable). The warrants will subject to redemption, as further described in Note 6.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">All of the Public Shares contain
a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#8217;s liquidation, if there
is a stockholder vote or tender offer in connection with the Company&#8217;s Business Combination and in connection with certain amendments
to the Company&#8217;s amended and restated certificate of incorporation (the &#8220;Certificate of Incorporation&#8221;). In accordance
with Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codifications (&#8220;ASC&#8221;) 480,&#160;<i>Distinguishing
Liabilities from Equity</i>&#160;(&#8220;ASC 480&#8221;) Subtopic 10-S99, redemption provisions not solely within the control of a company
require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares were issued with
other freestanding instruments (i.e., Public Warrants), the initial carrying value of Class A Common Stock classified as temporary equity
was the allocated proceeds determined in accordance with ASC 470-20 &#8220;Debt with Conversion and other Options&#8221;. The Class A
Common Stock is subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option
to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable
that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the
redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of
each reporting period. The Company has elected to recognize the changes immediately. Although redemptions cannot cause the Company&#8217;s
net tangible assets to fall below $<span id="xdx_906_ecustom--NetTangibleAssets_c20220331_pp0p0" title="Net tangible assets"><ix:nonFraction name="LFAC:NetTangibleAssets" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,001</ix:nonFraction></span>, the Public Shares are redeemable and are classified as such on the balance sheet until such
date that a redemption event takes place.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Redemptions of the Company&#8217;s
Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to
the Company&#8217;s Business Combination. If the Company seeks stockholder approval of the Business Combination, the Company will proceed
with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination, or such other vote as required
by law or stock exchange rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the
Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to the Certificate of Incorporation,
conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing
a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements,
or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction
with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval
in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares
purchased during or after the IPO in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem
their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Notwithstanding the foregoing,
the Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person
with whom such stockholder is acting in concert or as a &#8220;group&#8221; (as defined under Section 13 of the Securities Exchange Act
of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares with respect to more than an aggregate
of 15% or more of the Class A Common Stock sold in the Initial Public Offering, without the prior consent of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company&#8217;s Sponsor, officers
and directors (collectively, the &#8220;Initial Stockholders&#8221;) have agreed not to propose an amendment to the Certificate of Incorporation
that would affect the substance or timing of the Company&#8217;s obligation to redeem 100% of its Public Shares if the Company does not
complete a Business Combination, unless the Company provides the Public Stockholders with the opportunity to redeem their shares of Class
A Common Stock in conjunction with any such amendment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">If the Company is unable to complete
a Business Combination within 15 months from the closing of the IPO (unless extended in connection with an Extension Election as described
below or as a result of an amendment to our amended and restated certificate of incorporation, which would require the approval of the
holders of at least 65% of all of the Company&#8217;s then outstanding common stock) (&#8220;Combination Period&#8221;), the Company will (i) cease all
operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter,
redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including
interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company&#8217;s franchise
and income taxes (less up to $<span id="xdx_907_ecustom--DissolutionExpenses_c20220101__20220331_pp0p0" title="Dissolution expenses"><ix:nonFraction name="LFAC:DissolutionExpenses" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span>&#160;of interest to pay dissolution expenses), divided by the number of then outstanding Public
Shares, which redemption will completely extinguish Public Stockholders&#8217; rights as stockholders (including the right to receive
further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of directors, dissolve and liquidate,
subject in each case to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of
other applicable law. However, if the Company anticipates that it may be unable to complete an initial business combination within 15
months, it may, but is not obligated to, extend the period of time to complete a business combination up to six times by an additional
period of one month each time (for a total of up to 21 months) (each such one-month extension of the prescribed time period, an &#8220;Extension
Election&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<ix:exclude><p id="xdx_234_zEViSaBCF7qc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 9 -->
    <div id="xdx_239_zUYwCKuX8xok" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23C_ziNa2RfTHbc9" style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div id="xdx_238_zKthD2ELJN3" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zjLRVFnJ44E4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Initial Stockholders have agreed
to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the
Combination Period. However, if the Initial Stockholders should acquire Public Shares in or after the Initial Public Offering, they will
be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a
Business Combination within the Combination Period. The underwriter has agreed to waive its rights to its deferred underwriting fees (see
Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and,
in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption
of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available
for distribution (including Trust Account assets) will be only $10.20 per share held in the Trust Account. In order to protect the amounts
held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services
rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction
agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party
who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims
under the Company&#8217;s indemnity of the underwriter against certain liabilities, including liabilities under the Securities Act of
1933, as amended (the &#8220;Securities Act&#8221;). Moreover, in the event that an executed waiver is deemed to be unenforceable against
a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to
reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all
vendors, service providers (except the Company&#8217;s independent registered public accounting firm), prospective target businesses or
other entities with which the Company does business, execute agreements waiving any right, title, interest or claim of any kind in or
to monies held in the Trust Account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="letter-spacing: 0.4pt"><b><i>Risks and
Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">In March&#160;2020,
the World Health Organization declared the outbreak of a novel coronavirus (&#8220;COVID-19&#8221;) as a pandemic which continues to spread
throughout the United States and the world. As of the date the financial statements were issued, there is considerable uncertainty around
the expected duration of this pandemic. Management continues to evaluate the impact of the COVID-19 pandemic and the Company has concluded
that, while it is reasonably possible that COVID-19 could have a negative effect on the Company&#8217;s ability to identify a target company
for a Business Combination, the specific impact is not readily determinable as of the date of the unaudited condensed financial statements.
The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="letter-spacing: 0.4pt"><b><i>Liquidity
and Capital Resources</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">As of March 31, 2022, the Company
had $<span id="xdx_905_eus-gaap--OtherOperatingIncome_c20220101__20220331_pp0p0" title="Operating Loss"><ix:nonFraction name="us-gaap:OtherOperatingIncome" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">71,604</ix:nonFraction></span>&#160;in its operating bank account, $<span id="xdx_903_ecustom--SecuritiesHeldInTrustAccount_iI_c20220331_zvUg7vR2PKm3" title="Securities held in trust account"><ix:nonFraction name="LFAC:SecuritiesHeldInTrustAccount" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">264,079,072</ix:nonFraction></span>&#160;in securities held in the Trust Account to be used for a Business Combination
or to repurchase or redeem its common stock in connection therewith and working capital of $<span id="xdx_90A_ecustom--WorkingCapitalDeficit_c20220331_pp0p0" title="Working capital deficit"><ix:nonFraction name="LFAC:WorkingCapitalDeficit" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">264,991</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company&#8217;s liquidity needs
prior to the consummation of the IPO were satisfied through the payment of $25,000 from the Sponsor to cover certain offering costs on
the Company&#8217;s behalf in exchange for issuance of Founder Shares (Note 4) and a promissory note, as amended, from the Sponsor (see
Note 4). Subsequent to the IPO, the Company&#8217;s liquidity needs have been satisfied through a portion of the net proceeds from the
Private Placement. Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account
for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for
travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.
In order to finance transaction costs in connection with a Business Combination, the Company will need to raise additional capital through
loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company&#8217;s officers, directors
and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable
in their sole discretion, to meet the Company&#8217;s working capital needs. As of March 31, 2022, there were no amounts outstanding under
any Working Capital Loans. Subsequent to March 31, 2022, the Company obtained a loan from its Sponsor
(see Note 8).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Based on the foregoing, management
believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation
of a Business Combination or one year from the date of this filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zQZnue5vrvK4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2 &#8212;&#160;<span id="xdx_829_zIKcjq0S7ZRb">Summary of Significant Accounting
Policies</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"><p id="xdx_846_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zeUfUhw0H3sj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86C_z8vCEmUH9mAl">Basis of Presentation</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited condensed
financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of
America (&#8220;U.S. GAAP&#8221;) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do
not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed financial
statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and
results for the periods presented. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results
that may be expected through December 31, 2022.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The accompanying unaudited condensed
financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report
on Form 10-K and the final prospectus filed by the Company with the SEC on March 25, 2022 and November 17, 2021, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 10 -->
    <div id="xdx_23C_zYARwGcLYu6l" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_236_zjUFS4sbV9l4" style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div id="xdx_232_zYbHseh0oVib" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zCk9khqlPHVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="LFAC:EmergingGrowthCompanyPolicyTextBlock"><p id="xdx_846_ecustom--EmergingGrowthCompanyPolicyTextBlock_zuOq5M7MRbw5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_863_zEUUNtwIogK6">Emerging Growth Company</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company is an emerging growth
company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), which exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging
growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth
companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period,
which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company,
as an emerging growth company, will adopt the new or revised standard at the time private companies adopt the new or revised standard.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This may make comparison of the
Company&#8217;s unaudited condensed financial statement with those of another public company that is neither an emerging growth company
nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential
differences in accounting standards used.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_84A_eus-gaap--UseOfEstimates_zDeLotEQUKhg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="letter-spacing: 0.4pt"><b><i><span id="xdx_868_z0Zyxnq8rSTd">Use of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements
in conformity with&#160;<span style="letter-spacing: 0.2pt">U.S.&#160;</span>GAAP requires the Company<span style="letter-spacing: -0.5pt">&#8217;</span>s
management to make estimates and a<span style="letter-spacing: 0.05pt">s</span>sumptions that a<span style="letter-spacing: -0.15pt">f</span>fect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed
financial statements. Significant estimates in these unaudited condensed financial statements include those related to the fair value
of Warrants. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current
information becomes available and accordingly the actual results could di<span style="letter-spacing: -0.15pt">f</span>fer significantly
from those estimates. It is at least reasonably possib<span style="letter-spacing: 0.05pt">l</span>e that the estimate of the e<span style="letter-spacing: -0.15pt">f</span>fects
of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in
formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could di<span style="letter-spacing: -0.15pt">f</span>fer
from those es<span style="letter-spacing: 0.05pt">t</span>imates.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zQMxconbzu2d" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86D_z55ncVpItbpd">Cash and Cash Equivalents</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company considers all short-term
investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did&#160;<span id="xdx_909_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20220331_zI4EW9KSiG49" title="Cash equivalents"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2022-03-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span>t have any
cash equivalents as of March 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:EquityMethodInvestmentsPolicy"><p id="xdx_846_eus-gaap--EquityMethodInvestmentsPolicy_zQsTjFkTBDc8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86C_zGrlzlPfjK8l">Investments Held in Trust Account</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">At March 31, 2022, substantially
all of the assets held in the Trust Account were held in U.S. Treasury securities. The Company&#8217;s investments held in the Trust Account
are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting
period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in unrealized gains
on marketable securities held in Trust Account in the accompanying unaudited condensed statement of operations. The estimated fair values
of investments held in Trust Account are determined using available market information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="LFAC:OfferingCostsAssociatedWithIPOPolicyTextBlock"><p id="xdx_848_ecustom--OfferingCostsAssociatedWithIPOPolicyTextBlock_zeD2emHd0tzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_866_zf2ntkrYdBDd">Offering Costs Associated with the Initial Public
Offering</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.1pt; text-align: justify; text-indent: 36pt">Offering costs
amounted to $<span id="xdx_900_eus-gaap--DeferredOfferingCosts_iI_c20211119_zm7OkMUY9sR8" title="Offering Cost"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2021-11-19" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,030,508</ix:nonFraction></span>,
of which $<span id="xdx_902_eus-gaap--DeferredOfferingCosts_iI_pp0p0_c20211119__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zZNxVr3XXAC6" title="Offering Cost"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2021-11-19_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,621,728</ix:nonFraction></span>&#160;and
$<span id="xdx_902_eus-gaap--DeferredOfferingCosts_iI_pp0p0_c20211119__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicAndPrivateWarrantsMember_zKizjCXgk5Be" title="Offering Cost"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2021-11-19_custom_PublicAndPrivateWarrantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">408,779</ix:nonFraction></span>&#160;were
charged against the carrying value of Class A Common Stock and public and private warrants, respectively, as of November 19, 2021,
based on the relative value of the common shares and public and private Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.1pt; text-align: justify; text-indent: 36pt">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zweT7DK3MVLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86A_z8cXZzR6MlZ3">Concentration of Credit Risk</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.1pt; text-align: justify; text-indent: 36pt">Financial instruments
that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times,
may exceed the Federal Depository Insurance Corporation limit of $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_c20220331_pp0p0" title="FDIC amount"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">250,000</ix:nonFraction></span>. At March 31, 2022 and December 31, 2021, the Company has not
experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.1pt; text-align: justify; text-indent: 36pt">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zBnqROhbmtK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86D_zi0z1oOavhpj">Fair Value of Financial Instruments</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The fair value of the
Company&#8217;s assets and liabilities, which qualify as financial instruments under FASB ASC 820, &#8220;Fair Value Measurements
and Disclosures,&#8221; equals or approximates the carrying amounts represented in the accompanying unaudited condensed balance
sheet, primarily due to their short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_z7D5zBCJjMbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_868_zOxyKlQEpQjf">Income Taxes</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company complies with the accounting
and reporting requirements of FASB ASC Topic 740, &#8220;Income Taxes,&#8221; which requires an asset and liability approach to financial
accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial
statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws
and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established,
when necessary, to reduce deferred tax assets to the amount expected to be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 11 -->
    <div id="xdx_234_zQ33iF1Uvs8c" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_233_zR41FvXQofc7" style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div id="xdx_23E_zIhl00zf5On9" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zkchCN90OBhj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2022 </span>and December 31,
2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were
accrued for the payment of interest and penalties for the period from February 19, 2021 (date of inception) through March 31, 2022. The
Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from
its position. The Company is subject to income tax examinations by major taxing authorities since inception.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Deferred tax liabilities and assets
are determined based on the difference between the financial statement and tax basis of assets and liabilities, using enacted tax rates
in effect for the year in which the differences are expected to reverse. Current income taxes are based on the year&#8217;s income taxable
for federal and state income tax reporting purposes. Total tax provision may differ from the statutory tax rates applied to income before
provision for income taxes due principally to expenses charged which are not tax deductible.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt; background-color: white">The total expense / (benefit) for income taxes is comprised of the following:&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zlBPciDmADCk" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: center; text-indent: -10pt"><span id="xdx_8B1_zIQvA3v2Edfe" style="display: none">Schedule of Components of Income Tax Expense (Benefit)</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_497_20220101__20220331_zHvPjKjoKSYj" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">March&#160;31, 2022</td></tr>
  <tr id="xdx_40F_eus-gaap--CurrentIncomeTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 65%; text-align: left; text-indent: -10pt">Current expense / (benefit)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 25%; text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,381</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredIncomeTaxExpenseBenefit_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Deferred expense / (benefit)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">66,467</ix:nonFraction></td><td style="text-align: left">)&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_iN_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,993</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxExpenseBenefits_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Total income tax expense / (benefit)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="LFAC:IncomeTaxExpenseBenefits" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,907</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt; background-color: white">&#160;</p>



</ix:nonNumeric><p id="xdx_8A9_zFdrPCr6nBnc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The net deferred tax assets and liabilities in the
accompanying unaudited condensed balance sheets included the following components:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zveZ7OSNtGHb" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; text-align: center; padding-left: 10pt; text-indent: -10pt"><span id="xdx_8B6_zO7P7ND5NdNc" style="display: none">Schedule of deferred income tax assets and liabilities</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20220331_z0RRRxUl1u0d" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; text-align: center; padding-bottom: 0pt; padding-left: 10pt; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">March&#160;31, 2022</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; width: 65%; text-align: left; padding-bottom: 0pt; padding-left: 10pt; text-indent: -10pt">Deferred tax assets</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 25%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">117,397</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredTaxLiabilities_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: left; padding-bottom: 0pt; padding-left: 10pt; text-indent: -10pt">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;<span style="-sec-ix-hidden: xdx2ixbrl0454">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zU2Y4OnGlOel" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: left; padding-bottom: 0pt; padding-left: 10pt; text-indent: -10pt">Valuation allowance for deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">115,636</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-left: 10pt; padding-bottom: 0pt; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: left; padding-bottom: 0pt; text-indent: -10pt; padding-left: 20pt">Net deferred tax assets / (liabilities)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,761</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: center; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_498_20211231_zSBawQKIPQza" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2021</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_zuCUtAAHk44a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 65%; text-align: left; text-indent: -10pt">Deferred tax assets</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 25%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,929</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxLiabilities_iI_pp0p0_zQdXXHaD3JHd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;<span style="-sec-ix-hidden: xdx2ixbrl0462">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_z4fsDP26Utdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Valuation allowance for deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31,642</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_zJgksaS5mkDe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Net deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,287</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A1_zAajNk4qzbpf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">The deferred tax assets as of March 31, 2022 was comprised
of the tax effect of cumulative temporary differences as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 12 -->
    <div id="xdx_233_z48QYaq4dusi" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_237_z00zHruCEdd8" style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div id="xdx_230_zhXKlWBjqKH8" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zmWekM3pGbHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:SummaryOfDeferredTaxLiabilityNotRecognizedTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--SummaryOfDeferredTaxLiabilityNotRecognizedTextBlock_z0ZyE8hsWVfg" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: center; text-indent: -10pt"><span id="xdx_8BB_zF0JanzT2kEk" style="display: none">Summary of Deferred Tax Liability Not Recognized</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_49E_20220331_zgc9OALPQE42" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">March&#160;31, 2022</td></tr>
  <tr id="xdx_40C_ecustom--CapitalizedExpensesBeforeBusinessCombination_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 65%; text-align: left; text-indent: -10pt">Capitalized expenses before business combination</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 25%; text-align: right"><ix:nonFraction name="LFAC:CapitalizedExpensesBeforeBusinessCombination" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">117,397</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ValuationAllowanceForDeferredTaxAssets_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Valuation allowance for deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="LFAC:ValuationAllowanceForDeferredTaxAssets" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">115,636</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-indent: -10pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,761</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: center; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_495_20211231_zsw20XKLxj13" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December&#160;31, 2021</td></tr>
  <tr id="xdx_404_ecustom--CapitalizedExpensesBeforeBusinessCombination_iI_pp0p0_zZObX33e3mL" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 65%; text-align: left; text-indent: -10pt">Capitalized expenses before business combination</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 25%; text-align: right"><ix:nonFraction name="LFAC:CapitalizedExpensesBeforeBusinessCombination" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,929</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ValuationAllowanceForDeferredTaxAssets_iNI_pp0p0_di_z8VMpQF9r53l" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Valuation allowance for deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="LFAC:ValuationAllowanceForDeferredTaxAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31,642</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_pp0p0_zyLdGqWsyoLi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-indent: -10pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,287</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AE_zFmkPdQaHLzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In assessing the realization of
deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will
not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the
periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled
reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. At the period
ended March 31, 2022, the valuation allowance was $<span id="xdx_900_ecustom--ValuationAllowanceForDeferredTaxAssets_iNI_di_c20220331_zHJgDt7buUki" title="Valuation allowance for deferred tax assets"><ix:nonFraction name="LFAC:ValuationAllowanceForDeferredTaxAssets" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">115,636</ix:nonFraction></span>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">A reconciliation of the statutory federal income tax
rate (benefit) to the Company&#8217;s effective tax rate is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zCI0UazI23I2" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 3)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: center; text-indent: -10pt"><span id="xdx_8BF_zj8OkzQzNyeb" style="display: none">Schedule of effective tax rate</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">March&#160;31, 2022</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 65%; text-align: left; text-indent: -10pt">Statutory federal income tax rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 25%; text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20220331_zL58VXoocMrg" title="Statutory federal income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">State taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220101__20220331_zYEovGJNG3Ob" title="State taxes, net of federal tax benefit"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-<span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20220331_zaLcBK6ePnyl" title="Valuation allowance"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-01-01to2022-03-31" format="ixt:numunitdecimalin" decimals="INF" scale="-2" unitRef="Pure">28,41</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Income tax provision (benefit)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-<span id="xdx_909_ecustom--IncomeTaxProvisionBenefit_dp_c20220101__20220331_zr3fSSO0WqL" title="Income tax provision benefit"><ix:nonFraction name="LFAC:IncomeTaxProvisionBenefit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.41</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">December&#160;31,
2021</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding: 0pt 0pt 0pt 10pt; width: 65%; text-indent: -10pt"><span style="font: 10pt Times New Roman, Times, Serif">Statutory federal income tax rate</span></td>
<td style="width: 8%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 25%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210219__20211231_zIg5uYzJavN5" title="Statutory federal income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-02-192021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></span></td>
<td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: 10pt Times New Roman, Times, Serif">State taxes, net of federal tax benefit</span></td>
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20210219__20211231_z3j79JI9H5A8" title="State taxes, net of federal tax benefit"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2021-02-192021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></span></td>
<td><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: 10pt Times New Roman, Times, Serif">Valuation allowance</span></td>
<td style="padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: black 1pt solid"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: black 1pt solid; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-<span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210219__20211231_zQFbJtB9iR75" title="Valuation allowance"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2021-02-192021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13.05</ix:nonFraction></span></span></td>
<td style="padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: 10pt Times New Roman, Times, Serif">Income tax provision (benefit)</span></td>
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_ecustom--IncomeTaxProvisionBenefit_dp_c20210219__20211231_z7Di65LlJpJ3" title="Income tax provision benefit"><ix:nonFraction name="LFAC:IncomeTaxProvisionBenefit" contextRef="From2021-02-192021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.95</ix:nonFraction></span></span></td>
<td><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A6_zQKZJ0GJLsUg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="LFAC:ClassACommonStockSubjectToPossibleRedemptionPolicyTextBlock"><p id="xdx_843_ecustom--ClassACommonStockSubjectToPossibleRedemptionPolicyTextBlock_zvy5JkFvSQ0d" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86C_z37wpsjt57Qa">Class A Common Stock Subject to Possible Redemption</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company accounts for its Class
A Common Stock subject to possible redemption in accordance with the guidance in ASC 480. Conditionally redeemable Class A Common Stock
(including Class A Common Stock that features redemption rights that are either within the control of the holder or subject to redemption
upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other
times, Class A Common Stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A Common Stock sold in the IPO and
in connection with the exercise of the underwriter&#8217;s over-allotment option feature certain redemption rights that are considered
to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, on March 31, 2022,&#160;<span id="xdx_90C_eus-gaap--TemporaryEquityShareSubscriptions_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Temporary Equity"><ix:nonFraction name="us-gaap:TemporaryEquityShareSubscriptions" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,875,000</ix:nonFraction></span>&#160;shares
of Class A Common Stock subject to possible redemption is presented as temporary equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Immediately upon the closing of
the IPO and the exercise of the underwriter&#8217;s over-allotment option, the Company recognized the accretion from the initial book
value to redemption amount value. The change in the carrying value of redeemable shares of Class A Common Stock resulted in charges against
additional paid-in capital and accumulated deficit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">As of March 31, 2022, the shares
of Class A Common Stock reflected on the unaudited condensed balance sheet are reconciled on the following table:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<ix:exclude><p id="xdx_236_zUxivj9PwWZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 13 -->
    <div id="xdx_230_zyTYGiCgfyZ9" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23A_zBGrHb8vt7Vl" style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div id="xdx_235_zaH6l5FCUfXb" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zbZNOR7brhP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:TemporaryEquityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--TemporaryEquityTableTextBlock_zqHZRPEpa9be" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 4)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span id="xdx_8B1_z5Rr25kVcX5c" style="display: none">Schedule of reconciled balance sheet</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 65%; text-align: left; text-indent: -10pt">Gross proceeds</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--GrossProceeds_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zyyt98r7C1R2" title="Gross proceeds" style="width: 25%; text-align: right"><ix:nonFraction name="LFAC:GrossProceeds" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">258,750,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Less</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Fair value of Public Warrants at issuance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zdQwcXbgy22a" title="Fair value of Public Warrants at issuance" style="text-align: right">(<ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,727,500</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class A shares issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--ClassSharesIssuanceCosts_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ztJJPDQjYpL7" title="Class A shares issuance costs" style="text-align: right">(<ix:nonFraction name="LFAC:ClassSharesIssuanceCosts" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,621,728</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--AccretionOfCarryingValueToRedemptionValue_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zLaBPyR23ETa" title="Accretion of carrying value to redemption value" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="LFAC:AccretionOfCarryingValueToRedemptionValue" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,524,228</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class A Common Stock subject to possible redemption</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_iI_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zFSzlbTUOS9c" title="Class A Common Stock subject to possible redemption" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">263,925,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A2_zA4U6rJlPlqi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zcvdEUEurIpg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_865_zSDE6bajGZr2">Net income (loss) per Common Share</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company has two classes of
shares, which are referred to as Class A Common Stock and Class B Common Stock (the &#8220;Founder Shares&#8221;). Earnings and losses
are shared pro rata between the two classes of shares. A total of&#160;<span id="xdx_904_eus-gaap--SharesIssued_c20211119__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_pdd" title="Shares issued"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2021-11-19_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,937,500</ix:nonFraction></span>&#160;Public Warrants (see Note 3) and&#160;<span id="xdx_901_eus-gaap--SharesIssued_iI_c20211119__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_zPxdZ3UAB7sa" title="Shares issued"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2021-11-19_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,350,000</ix:nonFraction></span>&#160;Private
Placement Warrants (see Note 4) to purchase&#160;an aggregate of&#160;<span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211119__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Aggregate of shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-19_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,287,500</ix:nonFraction></span>&#160;shares of Class A Common Stock at $<span id="xdx_90D_eus-gaap--SharePrice_iI_c20211119__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zCJ8s551Hjvb" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-11-19_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span>&#160;per
share were issued on November 19, 2021. At March 31, 2022,&#160;no&#160;Public Warrants or Private Placement Warrants have been exercised.
The&#160;<span id="xdx_90C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zVQmzW7ZSfD1" title="Anti-diluted shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,287,500</ix:nonFraction></span>&#160;shares of Class A Common Stock for which the outstanding Public Warrants and Private Placement Warrants are exercisable
were excluded from diluted earnings per share for the period ended March 31, 2022 because they are contingently exercisable, and the contingencies
have not yet been met. As a result, diluted net loss per share of common stock is the same as basic net income loss per share of common
stock for the period. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net
loss per share for each class of stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zORvgME4E8ul" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 5)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B4_zHUwE8Q4sSdl" style="display: none">Schedule of basic and diluted net loss per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the period from January 1, 2022 through March 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic and diluted net loss per share:</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class A Common Stock</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class B Common Stock</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Allocation of net loss before accretion income</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--AllocationOfNetLoss_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pp0p0" title="Allocation of net loss before accretion income" style="width: 12%; text-align: right">(<ix:nonFraction name="LFAC:AllocationOfNetLoss" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">254,043</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--AllocationOfNetLoss_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_pp0p0" title="Allocation of net loss before accretion income" style="width: 12%; text-align: right">(<ix:nonFraction name="LFAC:AllocationOfNetLoss" contextRef="From2022-01-012022-03-31_custom_ClassBCommonStockMember455428828" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">63,511</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Accretion for Class A Common Stock to redemption value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zB9cTXjwohth" title="Net loss" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">254,043</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_zhsNLdoqzUGk" title="Net loss" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_ClassBCommonStockMember455428828" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">63,511</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--WeightedAverageSharesOutstanding_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Weighted average shares outstanding" style="text-align: right"><ix:nonFraction name="LFAC:WeightedAverageSharesOutstanding" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,875,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageSharesOutstanding_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_pdd" title="Weighted average shares outstanding" style="text-align: right"><ix:nonFraction name="LFAC:WeightedAverageSharesOutstanding" contextRef="From2022-01-012022-03-31_custom_ClassBCommonStockMember455428828" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,468,750</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic and diluted net loss per share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--BasicAndDilutionNetIncomeLossPerShare_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zEnuP7mCXcl1" title="Basic and diluted net loss per share" style="text-align: right">(<ix:nonFraction name="LFAC:BasicAndDilutionNetIncomeLossPerShare" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--BasicAndDilutionNetIncomeLossPerShare_c20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_zBhDsfvqn4K1" title="Basic and diluted net loss per share" style="text-align: right">(<ix:nonFraction name="LFAC:BasicAndDilutionNetIncomeLossPerShare" contextRef="From2022-01-012022-03-31_custom_ClassBCommonStockMember455428828" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 7.6pt 0 5pt; text-align: justify; text-indent: 22.3pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the period February 19, 2021 (inception) to March 31, 2021</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic and diluted net loss per share:</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class A Common Stock</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class B Common Stock</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Allocation of net loss before accretion income</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--AllocationOfNetLoss_pp0p0_c20210219__20210331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z6Rtdb3JgDyh" title="Allocation of net loss before accretion income" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0551">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--AllocationOfNetLoss_pp0p0_c20210219__20210331__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_zEOeBboWLWic" title="Allocation of net loss before accretion income" style="width: 12%; text-align: right">(<ix:nonFraction name="LFAC:AllocationOfNetLoss" contextRef="From2021-02-192021-03-31_custom_ClassBCommonStockMember455428828" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,613</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Accretion for Class A Common Stock to redemption value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NetIncomeLoss_pp0p0_c20210219__20210331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjYfW3fzKyD5" title="Net loss" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0555">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20210219__20210331__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_zeepdPxhzT9a" title="Net loss" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-02-192021-03-31_custom_ClassBCommonStockMember455428828" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,613</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageSharesOutstanding_c20210219__20210331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z95gUBpKM9C" title="Weighted average shares outstanding" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0559">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--WeightedAverageSharesOutstanding_c20210219__20210331__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_zhaQTTLjtSW8" title="Weighted average shares outstanding" style="text-align: right"><ix:nonFraction name="LFAC:WeightedAverageSharesOutstanding" contextRef="From2021-02-192021-03-31_custom_ClassBCommonStockMember455428828" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,468,750</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic and diluted net income (loss) per share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_ecustom--BasicAndDilutionNetIncomeLossPerShare_c20210219__20210331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zqEo6jNGROP7" title="Basic and diluted net income (loss) per share" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0563">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--BasicAndDilutionNetIncomeLossPerShare_c20210219__20210331__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_zCvqvIryQqH1" title="Basic and diluted net income (loss) per share" style="text-align: right">(<ix:nonFraction name="LFAC:BasicAndDilutionNetIncomeLossPerShare" contextRef="From2021-02-192021-03-31_custom_ClassBCommonStockMember455428828" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AB_zaGD51KUqjl6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="LFAC:WarrantInstrumentsPolicyTextBlock"><p id="xdx_846_ecustom--WarrantInstrumentsPolicyTextBlock_z89xiuVP7vb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_864_z7jCuFrVQPG6">Warrant Instruments</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company accounts for warrants
as either equity-classified or liability-classified instruments based on an assessment of the instruments&#8217; specific terms and applicable
authoritative guidance in ASC 480 and A<span style="letter-spacing: 0.05pt">S</span>C 815, Derivatives and Hedging (&#8220;ASC 815&#8221;).
The assessment considers whether the instruments are free standing financial instruments pursuant to&#160;<span style="letter-spacing: -0.05pt">A</span>SC
480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classificat<span style="letter-spacing: 0.05pt">i</span>on
under ASC 815, including whether the instruments are indexed to the Company<span style="letter-spacing: -0.5pt">&#8217;</span>s own common
shares and whether the instrument holders could pote<span style="letter-spacing: 0.05pt">n</span>tially require &#8220;net cash settlement&#8221;
in a circumstance outside of the Company<span style="letter-spacing: -0.5pt">&#8217;</span>s control, among other conditions for equity
classification. This as<span style="letter-spacing: 0.05pt">s</span>essment, which requires the use of professional judgment, was conducted
at the time of warrant issuance and as of each subsequent period end date while the instruments are outstanding. Management has concluded
that the Public&#160;<span style="letter-spacing: -0.75pt">W</span>arrants and Private Placement Warrants issued pursuant to the war<span style="letter-spacing: 0.05pt">r</span>ant
agreement qualify for equity accounting treatment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 14 -->
    <div id="xdx_23F_ztmROolhFyLc" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23F_zXwCrFY6fAe" style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div id="xdx_232_zC9zlutGlXi5" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zcmTM4sTWMq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:CompensationRelatedCostsPolicyTextBlock"><p id="xdx_84A_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zQASBhFR9806" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_864_zMqQzW1HAwrj">Stock Compensation Expense</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">In connection with the Company&#8217;s
IPO, founder&#8217;s shares were sold to certain independent directors by the Sponsor at the price of $<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pdd" title="Price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-03-31_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0004</ix:nonFraction></span>&#160;per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company accounts for stock-based
compensation expense in accordance with ASC 718, &#8220;Compensation &#8211; Stock Compensation&#8221; (&#8220;ASC 718&#8221;) under which
stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date and recognized over the
requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a
given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized
once the event is deemed probable to occur. Forfeitures are recognized as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span id="xdx_908_ecustom--NumberOfSharesSoldDescription_c20211103__20211109" title="Number of shares sold,description"><ix:nonNumeric contextRef="From2021-11-032021-11-09" name="LFAC:NumberOfSharesSoldDescription">The fair value of the 80,000 founder
shares sold to certain independent directors as of November 9, 2021, was $627,119, or $7.84 per share.</ix:nonNumeric></span>&#160;The Company used a Monte Carlo
Model Simulation to arrive at the fair value of the stock compensation. The key assumptions in the option pricing model utilized are assumptions
related to expected separation date of Units, anticipated business combination date, purchase price, share-price volatility, expected
term, exercise date, risk-free interest rate and present value. The expected volatility as of the IPO Closing Date was derived based upon
similar SPAC warrants and technology exchange traded funds which aligns with Company&#8217;s stated industry target and present value
factor was based on risk-free rate and terms until the exercise date. The Company&#8217;s Founder Shares sold to independent directors
(see Note 4) were deemed within the scope of ASC 718 and are subject to a performance condition, namely the occurrence of a Business Combination.
Compensation expense related to the Founder Shares transferred is recognized only when the performance condition is probable of occurrence,
or more specifically when a Business Combination is consummated. Therefore, no stock-based compensation expense has been recognized during
the period from February 19, 2021 (inception) through March 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmCYiBhdPwL" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_862_zou4jbikkoRb">Recent Accounting Pronouncements</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">In August 2020, the FASB issued
Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-06, Debt &#8212; debt with Conversion and Other Options (Subtopic 470-20) and
Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts
in an Entity&#8217;s Own Equity (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major
separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked
contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas.
The Company adopted ASU 2020-06 on February 19, 2021 (inception). Adoption of the ASU did not impact the Company&#8217;s financial position,
results of operations or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has reviewed other recent accounting pronouncements
and concluded that they are either not applicable to the Company, or no material effect is expected on the financial statement as a result
of future adoption.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="LFAC:InitialPublicOfferingDisclosureTextBlock"><p id="xdx_805_ecustom--InitialPublicOfferingDisclosureTextBlock_zzHD7n1oNAH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3 &#8212;&#160;<span id="xdx_821_znzQiXEMZc7l">Initial Public Offering</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Pursuant to the IPO, and including
the underwriter&#8217;s exercise of its over-allotment option, the Company sold&#160;<span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Sale of units in initial public offering"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2022-01-012022-03-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,875,000</ix:nonFraction></span>&#160;Units at a price of $<span id="xdx_90A_eus-gaap--SaleOfStockPricePerShare_c20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Sale of units per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-03-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span>&#160;per
Unit resulting in gross proceeds of $<span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220101__20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Gross proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2022-01-012022-03-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">258,750,000</ix:nonFraction></span>&#160;and net proceeds of $<span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20220101__20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Net proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2022-01-012022-03-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">243,738,425</ix:nonFraction></span>&#160;after deduction of offering costs. Each Unit
consists of one Public Share and one-half of one Public Warrant. Each Public Warrant entitles the holder to purchase one share of Class
A Common Stock at a price of $<span id="xdx_901_eus-gaap--SharePrice_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span>&#160;per share, subject to adjustment (see Note 6).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80D_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zMoX51CsstVf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4 &#8212;&#160;<span id="xdx_82A_zXHAcxNiwRC">Related Party Transactions</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Founder Shares</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">On March 5, 2021, the Sponsor acquired&#160;<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210301__20210305__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pdd" title="Number of shares issued, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-03-012021-03-05_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100</ix:nonFraction></span>&#160;shares
of the Company&#8217;s common stock. On March 15, 2021, the Company effectuated a recapitalization of the Company, which included a <span id="xdx_90F_eus-gaap--StockholdersEquityNoteStockSplit_c20210301__20210315_z8Sx5yFAocpb" title="Stock split, description"><ix:nonNumeric contextRef="From2021-03-012021-03-15" name="us-gaap:StockholdersEquityNoteStockSplit">64,687.50-for-1
stock split</ix:nonNumeric></span>, resulting in an aggregate of&#160;6,468,750&#160;Founder Shares outstanding. On June 21, 2021, the Company effectuated a
recapitalization of the Company, which included a&#160;<span id="xdx_903_eus-gaap--StockholdersEquityNoteStockSplit_c20210601__20210621_zHaDOKx2XxW9" title="Stock split, description"><ix:nonNumeric contextRef="From2021-06-012021-06-21" name="us-gaap:StockholdersEquityNoteStockSplit">1.11-for-1 stock split</ix:nonNumeric></span>, resulting in an aggregate of&#160;<span id="xdx_902_ecustom--AggregateOfSharesOutstanding_iI_c20210621__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zXamkGN45KI1" title="Common stock, Shares outstanding"><ix:nonFraction name="LFAC:AggregateOfSharesOutstanding" contextRef="AsOf2021-06-21_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,187,500</ix:nonFraction></span>&#160;Founder
Shares outstanding. On October 26, 2021, the Company effectuated a recapitalization of the Company, which included a<span id="xdx_908_eus-gaap--StockholdersEquityReverseStockSplit_c20211001__20211026_zHAPDJTfp0pa" title="Reverse stock split, description"><ix:nonNumeric contextRef="From2021-10-012021-10-26" name="us-gaap:StockholdersEquityReverseStockSplit">&#160;1-for-1.11 reverse
stock split</ix:nonNumeric></span>, resulting in an aggregate of&#160;<span id="xdx_901_ecustom--AggregateOfSharesOutstanding_c20211026__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_pdd" title="Common stock, Shares outstanding"><ix:nonFraction name="LFAC:AggregateOfSharesOutstanding" contextRef="AsOf2021-10-26_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,468,750</ix:nonFraction></span>&#160;Founder Shares outstanding (up to&#160;<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20211001__20211026__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_pdd" title="Number of shares forfeiture"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2021-10-012021-10-26_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">843,750</ix:nonFraction></span>&#160;of which were subject
to forfeiture if the underwriter&#8217;s over-allotment option was not exercised in full). Since the underwriter exercised its over-allotment
option in full, the Sponsor did not forfeit any Founder Shares. The Sponsor subsequently transferred an aggregate of&#160;<span id="xdx_903_ecustom--FounderShares_c20220101__20220331_pdd" title="Founder Shares"><ix:nonFraction name="LFAC:FounderShares" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">80,000</ix:nonFraction></span>&#160;Founder
Shares to the members of the Company&#8217;s board of directors for the same per-share consideration that it originally paid for such
shares, resulting in the Sponsor holding&#160;<span id="xdx_900_ecustom--FounderShares_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zAPXwjvimLhh" title="Founder Shares"><ix:nonFraction name="LFAC:FounderShares" contextRef="From2022-01-012022-03-31_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,388,750</ix:nonFraction></span>&#160;Founder Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Founder Shares will automatically
convert into shares of Class A Common Stock at the time of the Company&#8217;s initial Business Combination and are subject to certain
transfer restrictions. Holders of Founder Shares may also elect to convert their shares of Class B Common Stock into an equal number of
shares of Class A Common Stock, subject to adjustment, at any time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 15 -->
    <div id="xdx_231_zom65RrQU4N8" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_234_zgKJJLB6jHq2" style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div id="xdx_23A_zVwWSRjOpa2d" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zmL8MgJCb7o5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Initial Stockholders have
agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of:
(A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if
the last sale price of the Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends,
reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150
days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock
exchange or other similar transaction that results in all of the Company&#8217;s stockholders having the right to exchange their
shares of common stock for cash, securities or other property.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Private Placement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">On November 19, 2021, simultaneously
with the consummation of the IPO and the underwriter&#8217;s exercise of its over-allotment option, the Company consummated the issuance
and sale of&#160;<span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211101__20211119__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_pdd" title="Sale of units in initial public offering"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-11-012021-11-19_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,350,000</ix:nonFraction></span>&#160;Private Placement Warrants in a Private Placement at a price of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_c20220331__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_zD5yVct2Mcah" title="Sale of units per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span>&#160;per Private Placement Warrant,
generating gross proceeds of $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20211101__20211119__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pp0p0" title="Gross proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2021-11-012021-11-19_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,350,000</ix:nonFraction></span>. Each Private Placement Warrant is exercisable to purchase one share of Class A Common Stock
at a price of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_c20220331__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zHysQhQgIrK7" title="Sale of units per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-03-31_custom_ClassACommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span>&#160;per share. A portion of the proceeds from the Private Placement was added to the proceeds from the IPO being
held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the
sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable
law), and the Private Placement Warrants and all underlying securities will be worthless.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Related Party Loans</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">On March 5, 2021, the Sponsor agreed
to loan the Company an aggregate of up to $<span id="xdx_902_eus-gaap--LoansPayable_c20210305__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pp0p0" title="Loans payable"><ix:nonFraction name="us-gaap:LoansPayable" contextRef="AsOf2021-03-05_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">300,000</ix:nonFraction></span>&#160;to cover expenses related to the IPO pursuant to a promissory note (the &#8220;Note&#8221;).
On June 18, 2021, the Sponsor amended the Note to increase the principal amount to $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20210618__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pp0p0" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-18_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">600,000</ix:nonFraction></span>. The loan was non-interest bearing and payable
on the earlier of March 31, 2022 or the completion of the IPO. A total of $<span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_c20210301__20210305__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pp0p0" title="Repayment of Promissory Note"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2021-03-012021-03-05_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">425,000</ix:nonFraction></span>&#160;under the Note was borrowed from the Sponsor and
repaid in full from the proceeds of the Initial Public Offering not being placed in the Trust Account on November 19, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">In addition, in order to finance
transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s
officers and directors may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital Loans&#8221;).
If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account
released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the
event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the
Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing,
the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans.
The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#8217;s
discretion, up to $<span id="xdx_901_ecustom--WorkingCapitalLoans_iI_dm_c20220331_zCTu7K7sLQeg" title="Working Capital Loans"><ix:nonFraction name="LFAC:WorkingCapitalLoans" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="3" unitRef="USD">1.5</ix:nonFraction></span>&#160;million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity
at a price of $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20220331_pdd" title="Conversion Price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span>&#160;per warrant. The warrants would be identical to the Private Placement Warrants. As of March 31, 2022, no Working
Capital Loans were outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Support Services</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Effective November 16, 2021,
the Company entered into an Administrative Support Agreement with an entity affiliated with the Sponsor for office space and administrative
support services at a monthly fee of $<span id="xdx_90E_eus-gaap--AdministrativeFeesExpense_c20211101__20211116_pp0p0"><ix:nonFraction name="us-gaap:AdministrativeFeesExpense" contextRef="From2021-11-012021-11-16" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,000</ix:nonFraction></span>.
Since the consummation of the IPO, the Company has paid, and intends to continue paying until the earlier of the consummation of the
Business Combination or the Company&#8217;s liquidation, a fee of approximately $<span id="xdx_90E_eus-gaap--OtherExpenses_c20211101__20211116_pp0p0"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2021-11-012021-11-16" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,000</ix:nonFraction></span>&#160;per
month. <span id="xdx_90A_ecustom--SupportServicesDescription_c20220101__20220331_zZ67wrfZaqMa" title="Support services Description"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" name="LFAC:SupportServicesDescription">The Company recognized $45,000 and $0 for the three months ending March 31, 2022 and the period from February 19, 2021 (inception)
to March 31, 2021, respectively.</ix:nonNumeric></span> As of March 31, 2022, $<span id="xdx_906_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20220331_zQDAWsqFRUa1"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">45,000</ix:nonFraction></span>&#160;and
$<span id="xdx_90B_eus-gaap--AccruedLiabilitiesFairValueDisclosure_iI_pp0p0_c20220331_zmViktKlCAsh"><ix:nonFraction name="us-gaap:AccruedLiabilitiesFairValueDisclosure" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction>
</span>has been accrued for these services and is included in &#8220;Accounts payable and accrued expenses&#8221; in the accompanying
unaudited condensed balance sheets, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_808_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zPZKlxpTQCob" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5 &#8212;&#160;<span id="xdx_820_zpn5OCMB5Frd">Commitments and Contingencies</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Registration Rights</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The holders of Founder Shares,
Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration
rights (in the case of the Founder Shares, only after conversion of such shares to shares of Class A Common Stock) pursuant to a registration
rights agreement, dated November 16, 2021. These holders will be entitled to certain demand and &#8220;piggyback&#8221; registration rights.
However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities
Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear
the expenses incurred in connection with the filing of any such registration statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Underwriting Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company granted the underwriter
a&#160;<span id="xdx_908_ecustom--OptionForUnderwritersToPurchaseAdditionalUnitsTerm_dtD_c20220101__20220331_zdwsOfhYY6Va" title="Term of option for underwriters to purchase additional Units to cover over-allotments"><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" format="ixt-sec:durday" name="LFAC:OptionForUnderwritersToPurchaseAdditionalUnitsTerm">45</ix:nonNumeric></span>-day option from the date of the final prospectus relating to the IPO to purchase up to&#160;<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesOther_c20220101__20220331__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Purchase of additional units"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2022-01-012022-03-31_custom_UnderwritingAgreementMember_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,375,000</ix:nonFraction></span>&#160;additional Units
to cover over-allotments, if any, at the IPO price less underwriting fees. On November 19, 2021, the underwriter elected to fully exercise
its over-allotment option, purchasing&#160;<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesOther_c20211102__20211119__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zRcktRJNSvi1" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2021-11-022021-11-19_custom_UnderwritingAgreementMember_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,375,000</ix:nonFraction></span>&#160;of such additional Units.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The underwriter was paid a cash
underwriting discount of $<span id="xdx_90C_ecustom--CashUnderwritingDiscount_c20220101__20220331__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Cash underwriting discount"><ix:nonFraction name="LFAC:CashUnderwritingDiscount" contextRef="From2022-01-012022-03-31_custom_UnderwritingAgreementMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.20</ix:nonFraction></span>&#160;per Unit sold in the IPO, including the Units issued in connection with the underwriter&#8217;s exercise
of its over-allotment option, or $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220101__20220331_pp0p0" title="Aggregate value"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,175,000</ix:nonFraction></span>&#160;in the aggregate at the closing of the IPO. In addition, the underwriter is entitled
to a deferred underwriting fee of $<span id="xdx_90A_ecustom--DeferredUnderwritingFee_c20220101__20220331__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember_pdd" title="Deferred underwriting fee"><ix:nonFraction name="LFAC:DeferredUnderwritingFee" contextRef="From2022-01-012022-03-31_custom_UnderwritingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.35</ix:nonFraction></span>&#160;per unit, or $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220101__20220331__us-gaap--TransactionTypeAxis__custom--UnderwritingAgreementMember_zAERwlgUAS7k" title="Proceeds from initial offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-01-012022-03-31_custom_UnderwritingAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,056,250</ix:nonFraction></span>, from the closing of the IPO and the exercise of the underwriter&#8217;s
over-allotment option. The deferred underwriting fees will become payable to the underwriter from the amounts held in the Trust Account
solely if the Company completes a Business Combination, subject to the terms of the underwriting agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 16 -->
    <div id="xdx_234_zDzJREkJhIDi" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_235_ziTIBBzHycal" style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div id="xdx_23B_zl7ieQVA9hAb" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zQ5u3kjqBxp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zcp6e1bEuehk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 6 &#8212;&#160;<span id="xdx_820_z8ApTdFA9ue9">Stockholders&#8217; Deficit</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Common stock</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
A Common Stock&#8212;</i></b></span>The Company is authorized to issue <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span> shares of Class A Common Stock with a par value of
$<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share. As of March 31, 2022 and December 31, 2021, there were <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_do_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z5ZFSmcY7xOc" title="Common stock, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_do_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zYsNzrMu0K6a" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></span></span> (excluding <span id="xdx_90F_ecustom--CommonStockSubjectToPossibleRedemption_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common stock subject to possible redemption"><ix:nonFraction name="LFAC:CommonStockSubjectToPossibleRedemption" contextRef="AsOf2022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,875,000</ix:nonFraction></span> shares of Class A Common Stock subject
to possible redemption) shares of Class A Common Stock issued and outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
B Common Stock</i></b></span><i>&#8212;</i>The Company is authorized to issue <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></span> shares of Class B Common Stock with a par value
of $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share. As of March 31, 2022 and December 31, 2021, there were <span id="xdx_904_eus-gaap--CommonStockSharesIssued_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_c20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,468,750</ix:nonFraction></ix:nonFraction></span></span> shares of Class B Common Stock issued and outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock</i></b></span>&#8212;The Company is authorized to issue&#160;<span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_c20220331_zFPx1ylawSl3" title="Preferred Stock, Shares Authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span>&#160;shares of preferred stock with a par value of $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220331_z4grXhLDY9Y8" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>&#160;per
share with such designations, voting and other rights and preferences as may be determined from time to time by the Company&#8217;s board
of directors. For the period presented, there were&#160;<span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_do_c20220331_z9mPygBMSfAk" title="Preferred stock, shares issued"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20220331_zRKxLqYaB2w3" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-03-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-03-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></span></span>&#160;shares of preferred stock issued or outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants</i></b></span>&#8212;As
of March 31, 2022 and December 31, 2021, the Company had <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightOutstanding_c20220331__us-gaap--AwardTypeAxis__custom--PublicWarrantsMember_pdd" title="Warrants outstanding"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20211231__us-gaap--AwardTypeAxis__custom--PublicWarrantsMember_z7o4Q020FdG8" title="Warrants outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-03-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-12-31_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,937,500</ix:nonFraction></ix:nonFraction></span></span> Public Warrants and <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_c20220331__us-gaap--AwardTypeAxis__custom--PrivatePlacementWarrantsMember_pdd" title="Warrants outstanding"><span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20211231__us-gaap--AwardTypeAxis__custom--PrivatePlacementWarrantsMember_zsAbPJPkMgC4" title="Warrants outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-03-31_custom_PrivatePlacementWarrantsMember455430234" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,350,000</ix:nonFraction></ix:nonFraction></span></span> Private Placement Warrants outstanding.
The Company has determined that warrants issued in connection with its IPO in November 2021 are subject to treatment as equity. At IPO,
the Company utilized a Monte Carlo simulation model to value the Warrants. Inherent in a Monte Carlo simulation are assumptions related
to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of
its ordinary shares based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate
is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants.
The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical
rate, which the Company anticipates to remain at zero, the fair value of the Public and Private Placement warrants on IPO was $0.52/warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Public Warrants will become
exercisable 30 days after the completion of a Business Combination. No warrants will be exercisable for cash unless the Company has an
effective and current registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants and a
current prospectus relating to such shares of Class A Common Stock. Notwithstanding the foregoing, if a registration statement covering
the shares of Class A Common Stock issuable upon exercise of the Public Warrants is not effective within a specified period following
the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during
any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant
to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another
exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire
five years after the completion of a Business Combination or earlier upon redemption or liquidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Redemption of warrants when the price per share
of Class A Common Stock equals or exceeds $<span id="xdx_90B_ecustom--ShareRedemptionPricePerShare_c20220101__20220331_zBeCJ1kR6K3c" title="Share redemption price per share"><ix:nonFraction name="LFAC:ShareRedemptionPricePerShare" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.00</ix:nonFraction></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Once the warrants become exercisable, the Company
may redeem the outstanding warrants:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">in whole and not in part;</span></td></tr>
<tr style="vertical-align: top">
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">at a price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" title="Warrant price per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-03-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span>&#160;per warrant;</span></td></tr>
<tr style="vertical-align: top">
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">upon a minimum of 30 days&#8217; prior written notice of redemption, which we refer to as the &#8220;30-day redemption period&#8221; and</span></td></tr>
<tr style="vertical-align: top">
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">if, and only if, the last reported sale price of our Class A Common Stock for any 20 trading days within a 30-day trading period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders (the &#8220;Reference Value&#8221;) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities).</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company will not redeem the
warrants as described above unless an effective registration statement under the Securities Act covering the Class A Common Stock issuable
upon exercise of the warrants is effective and a current prospectus relating to those Class A Common Stock is available throughout the
30-day redemption period. If and when the warrants become redeemable by us, we may exercise our redemption right even if the Company is
unable to register or qualify the underlying securities for sale under all applicable state securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Redemption of warrants when the price per Class
A Common Stock equals or exceeds $<span id="xdx_902_ecustom--ShareRedemptionPricePerShare_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zepIO4ZNObJc" title="Share redemption price per share"><ix:nonFraction name="LFAC:ShareRedemptionPricePerShare" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_231_z0sP0nPXpk3a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 17 -->
    <div id="xdx_238_z9jyOqdRkIul" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_237_zaVcOgbB5at5" style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div id="xdx_238_zz8pMJQ4Uqph" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zvE0oAZNqz1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Once the warrants become exercisable, the Company
may redeem the outstanding warrants:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in whole and not in part</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth in the warrant agreement, subject to certain exceptions; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and only if, the Reference Value of the Company&#8217;s Class A Common Stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The &#8220;fair market value&#8221;
of the Company&#8217;s Class A Common Stock for the above purpose means the volume weighted average price of our Class A Common Stock
during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. The Company
will provide its warrant holders with the final fair market value no later than one business day after the 10-trading day period described
above ends. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A Common Stock per warrant (subject to adjustment). Any redemption of the warrants for Class A Common Stock will apply to both the Public Warrants
and the Private Placement Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">No fractional Class A Common Stock
will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company
will round down to the nearest whole number of the number of Class A Common Stock to be issued to the holder. Please see the section entitled
&#8220;Description of Securities&#8212;Warrants&#8212;Public Stockholders&#8217; Warrants&#8221; for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">If the Company calls the Public
Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on
a &#8220;cashless basis,&#8221; as described in the warrant agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Private Placement Warrants
will be identical to the Public Warrants underlying the Units being sold in the IPO, except that the Private Placement Warrants and the
shares of Class A Common Stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable
until after the completion of a Business Combination, subject to certain limited exceptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The exercise price and number of
shares of Class A Common Stock issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of
a stock dividend, extraordinary dividend or our recapitalization, reorganization, merger or consolidation. However, the warrants will
not be adjusted for issuances of shares of Class A Common Stock at a price below their respective exercise prices. Additionally, in no
event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within
the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such
funds with respect to their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust
Account with the respect to such warrants. Accordingly, the warrants may expire worthless.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">In addition, if the Company issues
additional shares of Class A Common Stock or equity-linked securities for capital raising purposes in connection with the closing of a
Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A Common Stock (with such issue
price or effective issue price to be determined in good faith by the Company&#8217;s board of directors, and in the case of any such issuance
to the initial stockholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance),
(y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available
for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the
volume weighted average trading price of the Company&#8217;s Class A Common Stock during the 10 trading day period starting on the trading
day prior to the day on which the Company consummates a Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.20
per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market
Value or (ii) the price at which the Company issues the additional shares of Class A Common Stock or equity-linked securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock"><p id="xdx_80A_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_z7L5Rmmku3J5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 7 &#8212;&#160;<span id="xdx_825_zmmcCv4o2zle">Fair Value Measurements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The fair value of the Company&#8217;s
financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would have received in connection with
the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants
at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the
use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 18 -->
    <div id="xdx_232_zNjaLF9tG0jl" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_231_zbmtKMXXi1dh" style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div id="xdx_232_z2jXc3Pi6yuk" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_z2zBCeRzXozf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 1: Quoted prices in active markets for identical
assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with
sufficient frequency and volume to provide pricing information on an ongoing basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 2: Observable inputs other than Level 1 inputs.
Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets
or liabilities in markets that are not active.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 3: Unobservable inputs based on the Company&#8217;s
assessment of the assumptions that market participants would use in pricing the asset or liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">At
March 31, 2022 and December 31, 2021, the assets held in the Trust Account were held in U.S. treasury funds. All of the
Company&#8217;s investments held in the Trust Account are classified as trading securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table presents information
about the Company&#8217;s liabilities that are measured at fair value on a recurring basis at March 31, 2022 <span style="background-color: white">and
December 31, 2021</span> and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zHAD47qL5305" summary="xdx: Disclosure - Fair Value Measurements (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="font-weight: bold">&#160;</td>
<td style="font-weight: bold; text-align: center">&#160;</td>
<td style="font-weight: bold; text-align: center">&#160;</td>
<td style="font-weight: bold">&#160;</td>
<td style="font-weight: bold; text-align: center">&#160;</td>
<td style="font-weight: bold">&#160;</td>
<td style="font-weight: bold; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt; text-indent: 0pt; text-align: left"><b>March 31, 2022</b>&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="font-weight: bold">&#160;</td>
<td style="font-weight: bold; text-align: center">&#160;</td>
<td style="font-weight: bold; text-align: center">Quoted&#160;Prices&#160;in</td>
<td style="font-weight: bold">&#160;</td>
<td style="font-weight: bold; text-align: center">Significant&#160;Other</td>
<td style="font-weight: bold">&#160;</td>
<td style="font-weight: bold; text-align: center">Significant&#160;Other</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="font-weight: bold">&#160;</td>
<td style="font-weight: bold; text-align: center">&#160;</td>
<td style="font-weight: bold; text-align: center">Active&#160;Markets</td>
<td style="font-weight: bold">&#160;</td>
<td style="font-weight: bold; text-align: center">Observable&#160;Inputs</td>
<td style="font-weight: bold">&#160;</td>
<td style="font-weight: bold; text-align: center">Unobservable&#160;Inputs</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Level&#160;1)</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Level&#160;2)</td>
<td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Level&#160;3)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Assets:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td colspan="2" style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; width: 18%; text-align: left; text-indent: -10pt">Cash, and U.S. Treasury Securities</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 16%; text-align: right">1</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="text-align: left">$</td>
<td id="xdx_98F_eus-gaap--CashCashEquivalentsAndShortTermInvestments_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_pp0p0" title="Cash" style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextRef="AsOf2022-03-31_us-gaap_FairValueInputsLevel1Member_us-gaap_USTreasurySecuritiesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">264,079,072</ix:nonFraction></td>
<td style="width: 3%">&#160;</td>
<td id="xdx_98E_eus-gaap--CashCashEquivalentsAndShortTermInvestments_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_pp0p0" title="Cash" style="width: 17%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0703">&#8212;</span></td>
<td style="width: 3%">&#160;</td>
<td id="xdx_98D_eus-gaap--CashCashEquivalentsAndShortTermInvestments_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_pp0p0" title="Cash" style="width: 17%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0705">&#8212;</span></td></tr>
</table></ix:nonNumeric>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - Fair Value Measurements (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: left; text-indent: -10pt"><span style="font-size: 10pt"><b>December 31, 2021</b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>Quoted&#160;Prices&#160;in</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>Significant&#160;Other</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>Significant&#160;Other</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: center; text-indent: -10pt">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>Active&#160;Markets</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>Observable&#160;Inputs</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>Unobservable&#160;Inputs</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: center; text-indent: -10pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Level</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>(Level&#160;1)</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>(Level&#160;2)</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>(Level&#160;3)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt">Assets:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 18%; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt">Cash, and U.S. Treasury Securities</span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><span style="font-size: 10pt">1</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td id="xdx_98E_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zwKzZ6JVwIag" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_USTreasurySecuritiesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">263,937,611</ix:nonFraction></span></td>
    <td style="width: 3%">&#160;</td>
    <td id="xdx_985_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zm9XkT0wJKng" style="width: 17%; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0707">&#8212;</span></span></td>
    <td style="width: 3%">&#160;</td>
    <td id="xdx_984_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--CashAndCashEquivalentsAxis__us-gaap--USTreasurySecuritiesMember_zB36wxqQW5b9" style="width: 17%; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0708">&#8212;</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-03-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zijczZ3mH1f3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 8 &#8212; <span id="xdx_827_zS5ns38lbLD6">Subsequent Events</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluated subsequent events and transactions
that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 13, 2022, the Sponsor issued a convertible promissory note (the &#8220;Promissory Note&#8221;), pursuant to which the Company may
borrow up to an aggregate principal amount of $1,500,000</span>. The Promissory Note is non-interest bearing and payable on the earlier
of (i) February 19, 2023; provided that, if and to the extent the Company exercises its right pursuant to that certain Investment Management
Trust Agreement, dated as of November 16, 2021, between the Company and Continental Stock Transfer &amp; Trust Company, to extend the
above-referenced date of February 19, 2023 by up to six additional months, then the last day of such extended period; and (ii) the effective
date of the Business Combination (such earlier date, the &#8220;Maturity Date&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At the option of the Sponsor, at any time on or prior
to the Maturity Date, any amounts outstanding under the Promissory Note (or any portion thereof) up to $1,500,000 in the aggregate, may
be converted into warrants to purchase Class A Common Stock of the Company at a conversion price (the &#8220;Conversion Price&#8221;)
equal to $1.00 per whole warrant. <span style="background-color: white">As of May 11, 2022, there is an amount outstanding of $250,000
under the Promissory Note.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>



</ix:nonNumeric><p id="xdx_81E_zho6XpO29zc9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 19; Options: NewSection; Value: 16 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_007"></span>Item 2. Management&#8217;s Discussion and Analysis of Financial Condition
and Results of Operations.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">References to &#8220;we,&#8221; &#8220;us,&#8221;
&#8220;Company&#8221; or &#8220;our Company&#8221; refer to LF Capital Acquisition Corp. II. The following discussion and analysis of
the Company&#8217;s financial condition and results of operations should be read in conjunction with the financial statements and the
notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes
forward-looking statements that involve risks and uncertainties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Cautionary Note Regarding Forward-Looking Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This Quarterly Report on Form 10-Q includes forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended (the &#8220;Exchange Act&#8221;). When used in this Form 10-Q, words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221;
&#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend&#8221; and similar expressions, as they relate to us or the Company&#8217;s
management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions
made by, and information currently available to, the Company&#8217;s management. Actual results could differ materially from those contemplated
by the forward-looking statements as a result of certain factors detailed in our other filings with the SEC. Our actual results may differ
materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under &#8220;Part
II<b>&#8212;</b>Other Information. Item 1a. Risk Factors&#8221; and elsewhere in this Quarterly Report on Form 10-Q.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 20; Value: 16 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are an early-stage blank check company incorporated
in February 2021 as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition,
stock purchase, reorganization or similar business combination with one or more businesses. We completed our IPO on November 19, 2021.
We intend to effectuate our initial business combination using cash from the proceeds of the IPO and the sale of the private placement
warrants, our capital stock, debt or a combination of cash, stock and debt.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Since
completing our IPO, we have reviewed, and continue to review, a number of opportunities to enter into an initial business combination
with an operating business, but we are not able to determine at this time whether we will complete an initial business combination with
any of the target businesses that we have reviewed or with any other target business. We presently have no revenue, have had losses since
inception from incurring formation costs and have had no operations other than the active solicitation of a target business with which
to complete an initial business combination. </span>We expect to continue to incur significant costs in the pursuit of our acquisition
plans. We cannot assure you that our plans to raise capital or to complete our initial business combination will be successful.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Results of Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have neither engaged in any operations nor generated
any revenues to date. Our only activities through March 31, 2022 were organizational activities, those necessary to prepare for the IPO,
described below, and, after our IPO, identifying a target company for an initial business combination. We do not expect to generate any
operating revenues until after the completion of our initial business combination. We generate non-operating income in the form of interest
income on marketable securities held in the trust account. We incur expenses as a result of being a public company (for legal, financial
reporting, accounting and auditing compliance), as well as for due diligence expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended March 31, 2022, we
had a net loss of $317,554, which consisted of operating costs of $373,271, offset by an unrealized gain on marketable securities
held in the trust account of $141,460.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Liquidity and Capital Resources</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2022, the Company had $71,604&#160;in
its operating bank account, $264,079,072&#160;in securities held in the Trust Account to be used for a Business Combination or to repurchase
or redeem its common stock in connection therewith and working capital of $264,991.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior to the completion of the IPO, the Company&#8217;s
liquidity needs were satisfied through the payment of $25,000 from the Sponsor to cover certain offering costs on the Company&#8217;s
behalf in exchange for issuance of Founder Shares and a promissory note, as amended, from the Sponsor for a total of $425,000. The promissory
note from the Sponsor was paid in full on November 19, 2021. Subsequent to the IPO, the Company&#8217;s liquidity needs have been satisfied
through a portion of the net proceeds from the Private Placement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, in order to finance transaction
costs in connection with a Business Combination, the Company will need to raise additional capital through loans or additional
investments from its Sponsor, shareholders, officers, directors, or third parties. The Company&#8217;s officers, directors and
Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem
reasonable in their sole discretion, to meet the Company&#8217;s working capital needs. As of March 31, 2022, there were no amounts
outstanding under any Working Capital Loans. Subsequent to March 31, 2022, the Company obtained a loan from its Sponsor.
Please see the section entitled &#8220;Recent Developments&#8221; for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based on the foregoing, management believes that the
Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business
Combination or one year from the date of this filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Off-Balance Sheet Arrangements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2022, we had no obligations, assets
or liabilities, which would be considered o<span style="letter-spacing: -0.15pt">f</span>f-balance sheet arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Contractual Obligations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2022, we do not have any long-term
debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay affiliate of our
Sponsor a monthly fee of $15,000 for office space, utilities and secretarial and administrative and support. We began incurring these
fees on consummation of the IPO and will continue to incur these fees monthly until the earlier of the completion of our initial business
combination and our liquidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 21; Value: 16 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The underwriter is entitled to a deferred fee of $0.35&#160;per
unit sold in the IPO, or $9,056,250 in the aggregate. This deferred fee will be waived by the underwriter in the event that the Company
does not complete an initial business combination, subject to the terms of the underwriting agreement with respect to the Company&#8217;s
IPO.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Critical Accounting Policies and Estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the unaudited condensed financial
statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets
and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and income
and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following
as our critical accounting policies:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Class A Common Stock Subject to Possible Redemption</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="letter-spacing: -0.75pt">W</span>e account
for our <span style="letter-spacing: 0.15pt">Class A </span>Common Stock subject to possible redemption in accordance with the guidance
in Accounting Standards Codific<span style="letter-spacing: 0.05pt">a</span>tion (&#8220;ASC&#8221;) <span style="letter-spacing: -0.65pt">T</span>opic
480 &#8220;Distinguishing Liabilities from Equit<span style="letter-spacing: -0.6pt">y</span>.&#8221; Common stock subject to mandatory
redemption is classified as a liability <span style="letter-spacing: 0.05pt">i</span>nstrument and is measured at fair value. Conditionally
redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject
to redemption upon the occurrence of uncertain events not solely within our control) is class<span style="letter-spacing: 0.05pt">i</span>fied
as temporary equit<span style="letter-spacing: -0.6pt">y</span>. At all other times, common stock is classified as stockholders&#8217;
equit<span style="letter-spacing: -0.6pt">y</span>. Our <span style="letter-spacing: 0.2pt">Class A </span>Common Stock features certain
redemption rights that <span style="letter-spacing: 0.05pt">a</span>re considered to be outside of our control and subject to occurrence
of uncertain future events. Accordingl<span style="letter-spacing: -0.6pt">y</span>, <span style="letter-spacing: 0.5pt">our Class A </span>Common
Stock subject to possible red<span style="letter-spacing: -0.05pt">e</span>mption is presented as temporary equit<span style="letter-spacing: -0.6pt">y</span>,
outside of the stockholders&#8217; equity section of our balance sheets. The Company recognizes changes <span style="letter-spacing: 0.05pt">i</span>n
redemption value immediately as they occur and adjusts the carrying value of redeemable <span style="letter-spacing: 0.45pt">Class A </span>Common
Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable <span style="letter-spacing: 0.45pt">Class
A </span>Common Stock are a<span style="letter-spacing: -0.15pt">f</span>fected by cha<span style="letter-spacing: -0.15pt">r</span>ges
against additional paid in ca<span style="letter-spacing: 0.05pt">p</span>ital and accumulated deficit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Net Loss Per Ordinary Share</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net loss per share is computed by dividing net loss
by the weighted average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture
by the Sponso<span style="letter-spacing: -0.5pt">r</span>. <span style="letter-spacing: 0.15pt">The calculation of diluted loss per share
does not consider the effect of the warrants issued in connection with the IPO and warrants issued in the Private Placement since the
exercise of these warrants are contingent upon the occurrence of future events. For the three months ended </span>March 31, 2022, the
Company did not have any dilutive securities and/or other contracts that could, potentiall<span style="letter-spacing: -0.6pt">y</span>,
be exercised or converted into shares of comm<span style="letter-spacing: 0.05pt">o</span>n stock and then share in the earnings of the
Compan<span style="letter-spacing: -0.6pt">y</span>. As a result, diluted loss per share is the same as basic loss per share for the period
presented.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Recent Accounting Standards</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has reviewed recent accounting pronouncements
and concluded that they are either not applicable to the Company or no material effect is expected on the unaudited condensed financial
statements as a result of future adoption.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Recent Developments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 13, 2022, the Sponsor issued a Promissory Note, pursuant to which the Company may borrow up to an aggregate principal amount of
$1,500,000</span>. The Promissory Note is non-interest bearing and payable on the Maturity Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At the option of the Sponsor, at any time on or prior
to the Maturity Date, any amounts outstanding under the Promissory Note (or any portion thereof) up to $1,500,000 in the aggregate, may
be converted into warrants to purchase Class A Common Stock of the Company at the Conversion Price. <span style="background-color: white">As
of May 11, 2022, there is an amount outstanding of $250,000 under the Promissory Note.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_008"></span>Item 3. Quantitative and Qualitative Disclosures
About Market Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are a smaller reporting company as defined in Rule
12b-2 under the Exchange Act. As a result, pursuant to Item 305(e) of Regulation S-K, we are not required to provide the information required
by this Item.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_009"></span>Item 4. Controls and Procedures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Disclosure controls are procedures that are designed
with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Quarterly
Report on Form 10-Q, is recorded, processed, summarized, and reported within the time period specified in the SEC&#8217;s rules and forms.
Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management,
including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 22; Value: 16 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our management evaluated, with the participation of
our current chief executive officer and chief financial officer (our &#8220;Certifying Officers&#8221;), the effectiveness of our disclosure
controls and procedures as of March 31, 2022, pursuant to Rule&#160;13a-15(b) under the Exchange Act. Based upon that evaluation, our
Certifying Officers concluded that, as of March 31, 2022, our disclosure controls and procedures were effective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Changes in Internal Control Over Financial Reporting</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the quarter ended March 31, 2022, there has
been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect,
our internal control over financial reporting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="a_010"></span>PART II&#8212;OTHER INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_011"></span>Item 1. Legal Proceedings.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_012"></span>Item 1a. Risk Factors.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Factors that could cause our actual results to differ
materially from those in this Quarterly Report are any of the risks described in our Annual Report on Form 10-K filed with the SEC on
March 25, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial
condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results
of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of the date of this Quarterly Report on Form 10-Q,
there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC on March 25, 2022.
However, we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_013"></span>Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Unregistered Sales of Equity Securities</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 5, 2021, our Sponsor acquired 100 shares
of the Company&#8217;s common stock in exchange for a capital contribution of $25,000, or approximately $250.00 per share, in a private
placement. The acquisition of such shares was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities
Act. On March 15, 2021, we effected a 64,687.5-for-one forward stock split of our issued and outstanding shares of common stock and reclassified
those issued and outstanding shares into shares of Class B Common Stock. On June 21, 2021, we effected an approximately 1.11-for-one forward
stock split of our issued and outstanding shares of Class B Common Stock. On October 26, 2021, we effected an approximately one-for-1.11
reverse stock split of our issued and outstanding shares of Class B Common Stock. At the time of our IPO, the Sponsor held 6,468,750 founder
shares (reflecting an aggregate capital contribution of approximately $0.004 per share). The number of founder shares issued was determined
based on the expectation that such founder shares would represent 20% of the issued and outstanding shares of our common stock upon completion
of the IPO. On November 19, 2021, our Sponsor transferred 20,000 founder shares to each of our independent directors at their original
purchase price in a private placement. This issuance was made pursuant to the exemption from registration contained in Section 4(a)(2)
of the Securities Act. In addition, at the closing of our initial business combination, our anchor investor will be entitled to purchase
from our Sponsor an aggregate of 12.5% of the number of founder shares outstanding upon the final closing of the IPO, at a purchase price
of approximately $0.004 per share.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Use of Proceeds</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 19, 2021, the Company consummated its
IPO of 25,875,000 units, including 3,375,000 units issued pursuant to the full exercise of the underwriter&#8217;s over-allotment option.
Each unit consists of one share of Class A Common Stock and one-half of one redeemable warrant of the Company, with each whole warrant
entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share. The units were sold at a price of $10.00
per unit, generating gross proceeds to the Company of $258,750,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A total of $263,925,000 of the proceeds from the IPO
(which amount includes $9,056,250 of the underwriter&#8217;s deferred fee) and the sale of the Private Placement Warrants, was placed
in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A., maintained by Continental Stock Transfer &amp; Trust Company, acting as
trustee. The proceeds held in the trust account may be invested by the trustee only in U.S. government securities with a maturity of 185
days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule
2a-7 under the Investment Company Act of 1940, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_014"></span>Item 3. Defaults Upon Senior Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 23; Value: 16 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_015"></span>Item 4. Mine Safety Disclosures.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_016"></span>Item 5. Other Information.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_017"></span>Item 6. Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following exhibits are filed as part of, or incorporated
by reference into, this Quarterly Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="border-bottom: Black 1pt solid; width: 10%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>No.</b></span></td>
<td style="padding-bottom: 1pt; width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 89%; text-align: justify; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Description of Exhibit</b></span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
<td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">31.1</span></td>
<td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><a href="e3726_ex31-1.htm"><span style="font: 10pt Times New Roman, Times, Serif">Certification of the Principal Executive Officer required by Rule 13a-14(a) or Rule 15(d)-14(a) </span></a></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">31.2</span></td>
<td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><a href="e3726_ex31-2.htm"><span style="font: 10pt Times New Roman, Times, Serif">Certification of the Principal Financial Officer required by Rule 13a-14(a) or Rule 15(d)-14(a) </span></a></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
<td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">32.1</span></td>
<td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="e3726_ex32-1.htm">Certification of the Principal Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350</a></span></td></tr>
<tr style="vertical-align: top; background-color: white">
<td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">32.2</span></td>
<td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="e3726_ex32-2.htm">Certification of the Principal Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350</a></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 24; Value: 16 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase"><b><span id="a_018"></span>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif"><b>LF Capital Acquisition Corp. II</b></span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; width: 50%; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 7%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 43%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: May 11, 2022</span></td>
<td colspan="2" style="border-bottom: Black 1pt solid"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Scott Reed</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Name: </span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott Reed</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font: 10pt Times New Roman, Times, Serif">Title:</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief Executive Officer</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
[{"type": "10-Q", "sequence": "1", "filename": "e3726_10-q.htm", "description": "FORM 10-Q", "secsgml_size_bytes": 459544}]
{"company-data": {"conformed-name": "LF Capital Acquisition Corp. II", "cik": "0001851266", "assigned-sic": "6770", "irs-number": "862195674", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "10-Q", "act": "34", "file-number": "001-41071", "film-number": "22915137"}, "business-address": {"street1": "1909 WOODALL RODGERS FREEWAY", "street2": "SUITE 500", "city": "DALLAS", "state": "TX", "zip": "75201", "phone": "(214) 741-6105"}, "mail-address": {"street1": "1909 WOODALL RODGERS FREEWAY", "street2": "SUITE 500", "city": "DALLAS", "state": "TX", "zip": "75201"}}
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark
One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the quarterly period ended
March 31, 2022
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the transition period from                 to
Commission
File No.
001-41071
LF Capital Acquisition Corp. II
(Exact name of registrant as specified in its charter)
Delaware
86-2195674
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
1909 Woodall Rodgers Freeway
,
Suite 500
Dallas
,
Texas
,
75201
(Address of Principal Executive Offices, including zip code)
(
214
)
741-6105
(Registrant's telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities
registered pursuant to Section 12(b) of the Act:
Units, each consisting of one share of Class A Common Stock and one-half of one Redeemable Warrant
LFACU
The
Nasdaq
Stock Market LLC
Class A Common Stock, par value $0.0001 per share
LFAC
The
Nasdaq
Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
LFACW
The
Nasdaq
Stock Market LLC
Indicate by check mark if the Registrant is a
well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes
☐ No ☒
Indicate
by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.
Yes
☐ No ☒
Indicate
by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
Yes
☒
No ☐
Indicate
by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).
Yes
☒
No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer,"
"smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☐
Accelerated filer
☐
Non-accelerated filer
☒
Smaller reporting company
☒
Emerging growth company
☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act
☐
Indicate
by check mark whether the Registrant has filed a report on and attestation to its management's assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report.
☐
Indicate
by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
☒
The
Registrant's shares were not listed on any exchange and had no value as of the last business day of the second fiscal quarter of
2021. The Registrant's units began trading on The Nasdaq Global Market ("Nasdaq") on November 17, 2021. The Registrant's
shares of Class A Common Stock and warrants began separate trading on Nasdaq on January 7, 2022. The aggregate market value of the units
outstanding, other than shares held by persons who may be deemed affiliates of the Registrant, computed by reference to the closing price
for the units on December 31, 2021, as reported on Nasdaq was $10.02.
As
of May 11, 2022, there were
25,875,000
shares of the Registrant's Class A Common Stock, par value $0.0001 per share
("Class A Common Stock") and
6,468,750
shares of the Registrant's Class B Common Stock, par value $0.0001
per share ("Class B Common Stock") issued and outstanding.
LF CAPITAL ACQUISITION CORP. II
Quarterly Report on Form 10-Q
TABLE OF CONTENTS
Page
PART 1 – FINANCIAL INFORMATION
Item 1.
Interim Financial Statements (Unaudited)
1
Unaudited Condensed Balance Sheets as of March 31, 2022 and December 31,
2021
1
Unaudited Condensed Statements of Operations for the three months ended
March 31, 2022 and for the period February 19, 2021 (inception) to March 31, 2022
2
Unaudited Condensed Statements of Changes in Stockholders' Deficit
for the three months ended March 31, 2022 and for the period February 19, 2021 (inception) to March 31, 2021
3
Unaudited Condensed Statement of Cash Flows for the three months ended March 31,
2022 and for the period February 19, 2021 (inception) to March 31, 2021
4
Notes to Condensed Financial Statement (Unaudited)
5
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
17
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
19
Item 4.
Control and Procedures
19
PART II –
OTHER INFORMATION
Item 1.
Legal Proceedings
20
Item 1A.
Risk Factors
20
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
20
Item 3.
Defaults Upon Senior Securities
20
Item 4.
Mine Safety Disclosures
21
Item 5.
Other Information
21
Item 6.
Exhibits
21
SIGNATURES
22
i
Item 1. Interim Financial Statements (Unaudited)
LF CAPITAL ACQUISITION CORP. II
CONDENSED
BALANCE SHEETS
March 31, 2022 (Unaudited)
December 31, 2021
ASSETS
CURRENT ASSETS
Cash
$
71,604
$
325,250
Prepaid expenses and other assets
425,501
430,477
Total current assets
497,105
755,727
Prepaid expenses-non current
264,131
367,039
Deferred tax asset
1,761
19,287
Investments held in Trust Account
264,079,072
263,937,611
TOTAL ASSETS
$
264,842,069
$
265,079,664
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts payable and accrued expenses
$
177,733
$
60,313
Franchise tax payable
50,000
91,842
Income tax payable
4,381
—
Total current liabilities
232,114
152,155
Deferred underwriting fee payable
9,056,250
9,056,250
Total liabilities
$
9,288,364
$
9,208,405
COMMITMENTS AND CONTINGENCIES
Class A Common Stock subject to possible redemption, $
0.0001
par value,
25,875,000
shares issued and outstanding at redemption value of $
10.20
per share
263,925,000
263,925,000
STOCKHOLDERS' DEFICIT
Preferred stock, $
0.0001
par value;
1,000,000
shares authorized;
none
issued and outstanding
—
—
Class A Common Stock; $
0.0001
par value;
100,000,000
shares authorized;
none
issued or outstanding (excluding 25,875,000 shares subject to possible redemption)
—
—
Class B Common Stock; $
0.0001
par value;
10,000,000
shares authorized;
6,468,750
shares issued and outstanding
647
647
Additional paid-in capital
—
—
Accumulated deficit
(
8,371,942
)
(
8,054,388
)
Total stockholders' deficit
(
8,371,295
)
(
8,053,741
)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
$
264,842,069
$
265,079,664
The accompanying notes are an integral part of these unaudited condensed financial statements.
1
LF CAPITAL ACQUISITION CORP. II
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
For the three months ended March 31, 2022
For the period February 19, 2021 (inception) to March 31, 2021
OPERATING EXPENSES
General and administrative
$
387,107
$
3,613
Franchise tax
50,000
—
Loss from operations
437,107
3,613
OTHER INCOME
Unrealized gain on investments held in Trust Account
141,460
—
Total other income
141,460
—
LOSS BEFORE PROVISION FOR INCOME TAXES
(
295,647
)
(
3,613
)
Income tax expense
21,907
—
NET LOSS
$
(
317,554
)
$
(
3,613
)
Weighted average shares outstanding of Class A Common Stock
25,875,000
—
Basic and diluted net income per share, Class A
$
(
0.01
)
$
—
Weighted average shares outstanding of Class B Common Stock
6,468,750
6,468,750
Basic and diluted net loss per share, Class B
$
(
0.01
)
$
0.00
The accompanying notes are an integral part of these unaudited condensed financial statements.
2
LF CAPITAL ACQUISITION CORP. II
CONDENSED
STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (UNAUDITED)
FOR THE THREE MONTHS ENDED MARCH 31, 2022
Common stock
Additional
Total
Class A
Class B
paid-in
Accumulated
stockholders'
Shares
Amount
Shares
Amount
capital
deficit
deficit
Balance - 12/31/21
—
$
—
6,468,750
$
647
$
—
$
(
8,054,388
)
$
(
8,053,741
)
Net loss
—
—
—
(
317,554
)
(
317,554
)
Balance - 03/31/22
—
$
—
6,468,750
$
647
$
—
$
(
8,371,942
)
$
(
8,371,295
)
FOR THE PERIOD FEBRUARY 19, 2021 (INCEPTION) TO MARCH 31, 2021
Common stock
Additional
Total
Class A
Class B
paid-in
Accumulated
stockholders'
Shares
Amount
Shares
Amount
capital
deficit
equity
Balance - 02/19/21 (inception)
—
$
—
—
$
—
$
—
$
—
$
—
Issuance of Common Stock to initial stockholders
6,468,750
647
24,353
25,000
Net loss
—
—
—
—
—
(
3,613
)
(
3,613
)
Balance - 03/31/21
—
$
—
6,468,750
$
647
$
24,353
$
(
3,613
)
$
21,387
The accompanying notes are an
integral part of these unaudited condensed financial statements.
3
LF CAPITAL ACQUISITION CORP. II
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
For the three months ended March 31, 2022
For the period February 19, 2021 (inception) to March 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
$
(
317,554
)
$
(
3,613
)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in deferred tax asset
17,526
—
Unrealized gain on investments held in Trust Account
(
141,460
)
—
Changes in operating assets and liabilities:
Deferred offering costs
—
—
Prepaid expenses and other assets
107,883
—
Accounts payable and accrued expenses
117,420
3,598
Franchise tax payable
(
41,842
)
—
Income tax payable
4,381
—
Net cash flows used in operating activities
(
253,646
)
(
15
)
CASH FLOWS FROM INVESTING ACTIVITIES
—
—
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of Class B Common Stock to Sponsor
—
647
Paid in capital
—
24,353
Net cash flows provided by financing activities
—
25,000
NET CHANGE IN CASH
(
253,646
)
24,985
CASH, BEGINNING OF PERIOD
325,250
—
CASH, END OF PERIOD
$
71,604
$
24,985
The accompanying notes are an integral part of these unaudited condensed financial statements.
4
LF
CAPITAL
ACQUISITION CORP. I
NOTES TO C
ONDENSED
FINANCIAL STATEMENTS
March 31,
2022
(UNAUDITED
)
Note 1 –
Description of Organization and Business Operations
LF Capital Acquisition Corp. II
(the "Company") was incorporated in Delaware on February 19, 2021. The Company is a blank check company formed for the purpose
of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business
combination with one or more businesses or entities (the "Business Combination"). The Company has selected December 31 as
its fiscal year end.
The Company is not limited to a
particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging
growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of March 31, 2022, the Company
had not commenced any operations. All activity from February 19, 2021 (inception) through November 19, 2021, relates to the Company's
formation and Initial Public Offering ("IPO"), which is described below and, since the IPO, the search for a prospective Business
Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the
earliest. The Company will generate non-operating income in the form of interest income earned on investments from the proceeds derived
from the IPO. The registration statement for the Company's IPO was declared effective on November 16, 2021. On November 19, 2021,
the Company consummated the IPO and sold
22,500,000
units ("Units") with each Unit consisting of one share of Class
A Common Stock and one-half of one redeemable warrant to purchase one share of Class A Common Stock at $
11.50
per share (each, a
"Public Warrant") at $
10.00
per Unit, generating gross proceeds of $
225,000,000
, which is discussed in Note 3.
Simultaneously with the closing
of the IPO, the Company consummated the sale of
11,000,000
warrants at a price of $1.00 per warrant in a private placement
("Private Placement Warrants") to the Company's sponsor, Level Field Capital II, LLC (the "Sponsor"), the
underwriter of the IPO and certain funds and accounts managed by subsidiaries of a strategic investor (the "anchor investor"),
generating gross proceeds of $11,000,000 which is described in Note 4.
Simultaneously with the closing
of the IPO, the Company consummated the closing of the sale of
3,375,000
additional Units upon receiving notice of the underwriter's
election to fully exercise its overallotment option ("Overallotment Units"), generating additional gross proceeds of $
33,750,000
.
Simultaneously with the exercise of the overallotment, the Company consummated the Private Placement of an additional
1,350,000
Private
Placement Warrants to the Sponsor and the underwriter, generating gross proceeds of $
1,350,000
.
Offering costs for the IPO and
the exercise of the underwriter's over-allotment option amounted to $
15,030,508
, consisting of $
14,231,250
of underwriting
fees, of which $
9,056,250
is deferred and held in the Trust Account (defined below) and $
799,258
of other offering costs. As
described in Note 5, the $
9,056,250
of deferred underwriting fees payable is contingent upon the consummation of a Business Combination
within 15 months from the closing of IPO (or, following the extension of the period of time to complete the initial business combination
up to six times by an additional period of one month each time for a total of up to 21 months), subject to the terms of the underwriting
agreement.
Following the closing of the IPO
and the exercise of the underwriter's over-allotment option, $
263,925,000
($
10.20
per Unit) from the net proceeds from
the sale of the Units in the IPO and the Private Placement Warrants were placed in a trust account ("Trust Account") and have
been invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as
amended (the "Investment Company Act"), with a maturity of 180 days or less or in any open-ended investment company that holds
itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7
of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii)
the distribution of the Trust Account, as described below.
The Company's management
has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Warrants,
although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There
is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial
Business Combinations having an aggregate fair market value of at least
80
% of the assets held in the Trust Account (excluding the
deferred underwriting fees and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial
Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires
50
%
or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it
not to be required to register as an investment company under the Investment Company Act. There is no assurance the Company will be able
to successfully effect a Business Combination.
5
The Company will provide the holders
of the outstanding Public Shares (the "Public Stockholders") with the opportunity to redeem all or a portion of their Public
Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business
Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination
or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro
rata portion of the amount then in the Trust Account (initially anticipated to be $10.20 per Public Share, plus any pro rata interest
then in the Trust Account, net of taxes payable). The warrants will subject to redemption, as further described in Note 6.
All of the Public Shares contain
a redemption feature which allows for the redemption of such Public Shares in connection with the Company's liquidation, if there
is a stockholder vote or tender offer in connection with the Company's Business Combination and in connection with certain amendments
to the Company's amended and restated certificate of incorporation (the "Certificate of Incorporation"). In accordance
with Financial Accounting Standards Board ("FASB") Accounting Standards Codifications ("ASC") 480,
Distinguishing
Liabilities from Equity
("ASC 480") Subtopic 10-S99, redemption provisions not solely within the control of a company
require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares were issued with
other freestanding instruments (i.e., Public Warrants), the initial carrying value of Class A Common Stock classified as temporary equity
was the allocated proceeds determined in accordance with ASC 470-20 "Debt with Conversion and other Options". The Class A
Common Stock is subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option
to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable
that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the
redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of
each reporting period. The Company has elected to recognize the changes immediately. Although redemptions cannot cause the Company's
net tangible assets to fall below $
5,000,001
, the Public Shares are redeemable and are classified as such on the balance sheet until such
date that a redemption event takes place.
Redemptions of the Company's
Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to
the Company's Business Combination. If the Company seeks stockholder approval of the Business Combination, the Company will proceed
with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination, or such other vote as required
by law or stock exchange rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the
Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to the Certificate of Incorporation,
conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing
a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements,
or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction
with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval
in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares
purchased during or after the IPO in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem
their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.
Notwithstanding the foregoing,
the Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person
with whom such stockholder is acting in concert or as a "group" (as defined under Section 13 of the Securities Exchange Act
of 1934, as amended (the "Exchange Act")), will be restricted from redeeming its shares with respect to more than an aggregate
of 15% or more of the Class A Common Stock sold in the Initial Public Offering, without the prior consent of the Company.
The Company's Sponsor, officers
and directors (collectively, the "Initial Stockholders") have agreed not to propose an amendment to the Certificate of Incorporation
that would affect the substance or timing of the Company's obligation to redeem 100% of its Public Shares if the Company does not
complete a Business Combination, unless the Company provides the Public Stockholders with the opportunity to redeem their shares of Class
A Common Stock in conjunction with any such amendment.
If the Company is unable to complete
a Business Combination within 15 months from the closing of the IPO (unless extended in connection with an Extension Election as described
below or as a result of an amendment to our amended and restated certificate of incorporation, which would require the approval of the
holders of at least 65% of all of the Company's then outstanding common stock) ("Combination Period"), the Company will (i) cease all
operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter,
redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including
interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company's franchise
and income taxes (less up to $
100,000
of interest to pay dissolution expenses), divided by the number of then outstanding Public
Shares, which redemption will completely extinguish Public Stockholders' rights as stockholders (including the right to receive
further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the Company's remaining stockholders and the Company's board of directors, dissolve and liquidate,
subject in each case to the Company's obligations under Delaware law to provide for claims of creditors and the requirements of
other applicable law. However, if the Company anticipates that it may be unable to complete an initial business combination within 15
months, it may, but is not obligated to, extend the period of time to complete a business combination up to six times by an additional
period of one month each time (for a total of up to 21 months) (each such one-month extension of the prescribed time period, an "Extension
Election").
6
The Initial Stockholders have agreed
to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the
Combination Period. However, if the Initial Stockholders should acquire Public Shares in or after the Initial Public Offering, they will
be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a
Business Combination within the Combination Period. The underwriter has agreed to waive its rights to its deferred underwriting fees (see
Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and,
in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption
of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available
for distribution (including Trust Account assets) will be only $10.20 per share held in the Trust Account. In order to protect the amounts
held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services
rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction
agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party
who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims
under the Company's indemnity of the underwriter against certain liabilities, including liabilities under the Securities Act of
1933, as amended (the "Securities Act"). Moreover, in the event that an executed waiver is deemed to be unenforceable against
a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to
reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all
vendors, service providers (except the Company's independent registered public accounting firm), prospective target businesses or
other entities with which the Company does business, execute agreements waiving any right, title, interest or claim of any kind in or
to monies held in the Trust Account.
Risks and
Uncertainties
In March 2020,
the World Health Organization declared the outbreak of a novel coronavirus ("COVID-19") as a pandemic which continues to spread
throughout the United States and the world. As of the date the financial statements were issued, there is considerable uncertainty around
the expected duration of this pandemic. Management continues to evaluate the impact of the COVID-19 pandemic and the Company has concluded
that, while it is reasonably possible that COVID-19 could have a negative effect on the Company's ability to identify a target company
for a Business Combination, the specific impact is not readily determinable as of the date of the unaudited condensed financial statements.
The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Liquidity
and Capital Resources
As of March 31, 2022, the Company
had $
71,604
in its operating bank account, $
264,079,072
in securities held in the Trust Account to be used for a Business Combination
or to repurchase or redeem its common stock in connection therewith and working capital of $
264,991
.
The Company's liquidity needs
prior to the consummation of the IPO were satisfied through the payment of $25,000 from the Sponsor to cover certain offering costs on
the Company's behalf in exchange for issuance of Founder Shares (Note 4) and a promissory note, as amended, from the Sponsor (see
Note 4). Subsequent to the IPO, the Company's liquidity needs have been satisfied through a portion of the net proceeds from the
Private Placement. Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account
for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for
travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.
In order to finance transaction costs in connection with a Business Combination, the Company will need to raise additional capital through
loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company's officers, directors
and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable
in their sole discretion, to meet the Company's working capital needs. As of March 31, 2022, there were no amounts outstanding under
any Working Capital Loans. Subsequent to March 31, 2022, the Company obtained a loan from its Sponsor
(see Note 8).
Based on the foregoing, management
believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation
of a Business Combination or one year from the date of this filing.
Note 2 —
Summary of Significant Accounting
Policies
Basis of Presentation
The accompanying unaudited condensed
financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of
America ("U.S. GAAP") for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do
not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed financial
statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and
results for the periods presented. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results
that may be expected through December 31, 2022.
The accompanying unaudited condensed
financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report
on Form 10-K and the final prospectus filed by the Company with the SEC on March 25, 2022 and November 17, 2021, respectively.
7
Emerging Growth Company
The Company is an emerging growth
company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), which exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging
growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth
companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period,
which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company,
as an emerging growth company, will adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the
Company's unaudited condensed financial statement with those of another public company that is neither an emerging growth company
nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential
differences in accounting standards used.
Use of Estimates
The preparation of financial statements
in conformity with
U.S.
GAAP requires the Company
'
s
management to make estimates and a
s
sumptions that a
f
fect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed
financial statements. Significant estimates in these unaudited condensed financial statements include those related to the fair value
of Warrants. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current
information becomes available and accordingly the actual results could di
f
fer significantly
from those estimates. It is at least reasonably possib
l
e that the estimate of the e
f
fects
of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in
formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could di
f
fer
from those es
t
imates.
Cash and Cash Equivalents
The Company considers all short-term
investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did
no
t have any
cash equivalents as of March 31, 2022.
Investments Held in Trust Account
At March 31, 2022, substantially
all of the assets held in the Trust Account were held in U.S. Treasury securities. The Company's investments held in the Trust Account
are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting
period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in unrealized gains
on marketable securities held in Trust Account in the accompanying unaudited condensed statement of operations. The estimated fair values
of investments held in Trust Account are determined using available market information.
Offering Costs Associated with the Initial Public
Offering
Offering costs
amounted to $
15,030,508
,
of which $
14,621,728
and
$
408,779
were
charged against the carrying value of Class A Common Stock and public and private warrants, respectively, as of November 19, 2021,
based on the relative value of the common shares and public and private Warrants.
Concentration of Credit Risk
Financial instruments
that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times,
may exceed the Federal Depository Insurance Corporation limit of $
250,000
. At March 31, 2022 and December 31, 2021, the Company has not
experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments
The fair value of the
Company's assets and liabilities, which qualify as financial instruments under FASB ASC 820, "Fair Value Measurements
and Disclosures," equals or approximates the carrying amounts represented in the accompanying unaudited condensed balance
sheet, primarily due to their short-term nature.
Income Taxes
The Company complies with the accounting
and reporting requirements of FASB ASC Topic 740, "Income Taxes," which requires an asset and liability approach to financial
accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial
statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws
and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established,
when necessary, to reduce deferred tax assets to the amount expected to be realized.
8
ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2022
and December 31,
2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were
accrued for the payment of interest and penalties for the period from February 19, 2021 (date of inception) through March 31, 2022. The
Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from
its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Deferred tax liabilities and assets
are determined based on the difference between the financial statement and tax basis of assets and liabilities, using enacted tax rates
in effect for the year in which the differences are expected to reverse. Current income taxes are based on the year's income taxable
for federal and state income tax reporting purposes. Total tax provision may differ from the statutory tax rates applied to income before
provision for income taxes due principally to expenses charged which are not tax deductible.
The total expense / (benefit) for income taxes is comprised of the following:
March 31, 2022
Current expense / (benefit)
$
4,381
Deferred expense / (benefit)
(
66,467
)
Change in valuation allowance
83,993
Total income tax expense / (benefit)
$
21,907
The net deferred tax assets and liabilities in the
accompanying unaudited condensed balance sheets included the following components:
March 31, 2022
Deferred tax assets
$
117,397
Deferred tax liabilities
—
Valuation allowance for deferred tax assets
(
115,636
)
Net deferred tax assets / (liabilities)
$
1,761
December 31, 2021
Deferred tax assets
$
50,929
Deferred tax liabilities
—
Valuation allowance for deferred tax assets
(
31,642
)
Net deferred tax assets
$
19,287
The deferred tax assets as of March 31, 2022 was comprised
of the tax effect of cumulative temporary differences as follows:
9
March 31, 2022
Capitalized expenses before business combination
$
117,397
Valuation allowance for deferred tax assets
(
115,636
)
Total
$
1,761
December 31, 2021
Capitalized expenses before business combination
$
50,929
Valuation allowance for deferred tax assets
(
31,642
)
Total
$
19,287
In assessing the realization of
deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will
not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the
periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled
reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. At the period
ended March 31, 2022, the valuation allowance was $
115,636
.
A reconciliation of the statutory federal income tax
rate (benefit) to the Company's effective tax rate is as follows:
March 31, 2022
Statutory federal income tax rate
21.0
%
State taxes, net of federal tax benefit
0.0
%
Valuation allowance
-
28,41
%
Income tax provision (benefit)
-
7.41
%
December 31,
2021
Statutory federal income tax rate
21.0
%
State taxes, net of federal tax benefit
0.0
%
Valuation allowance
-
13.05
%
Income tax provision (benefit)
7.95
%
Class A Common Stock Subject to Possible Redemption
The Company accounts for its Class
A Common Stock subject to possible redemption in accordance with the guidance in ASC 480. Conditionally redeemable Class A Common Stock
(including Class A Common Stock that features redemption rights that are either within the control of the holder or subject to redemption
upon the occurrence of uncertain events not solely within the Company's control) is classified as temporary equity. At all other
times, Class A Common Stock is classified as stockholders' equity. The Company's Class A Common Stock sold in the IPO and
in connection with the exercise of the underwriter's over-allotment option feature certain redemption rights that are considered
to be outside of the Company's control and subject to occurrence of uncertain future events. Accordingly, on March 31, 2022,
25,875,000
shares
of Class A Common Stock subject to possible redemption is presented as temporary equity.
Immediately upon the closing of
the IPO and the exercise of the underwriter's over-allotment option, the Company recognized the accretion from the initial book
value to redemption amount value. The change in the carrying value of redeemable shares of Class A Common Stock resulted in charges against
additional paid-in capital and accumulated deficit.
As of March 31, 2022, the shares
of Class A Common Stock reflected on the unaudited condensed balance sheet are reconciled on the following table:
10
Gross proceeds
$
258,750,000
Less
Fair value of Public Warrants at issuance
(
6,727,500
)
Class A shares issuance costs
(
14,621,728
)
Plus:
Accretion of carrying value to redemption value
26,524,228
Class A Common Stock subject to possible redemption
$
263,925,000
Net income (loss) per Common Share
The Company has two classes of
shares, which are referred to as Class A Common Stock and Class B Common Stock (the "Founder Shares"). Earnings and losses
are shared pro rata between the two classes of shares. A total of
12,937,500
Public Warrants (see Note 3) and
12,350,000
Private
Placement Warrants (see Note 4) to purchase an aggregate of
25,287,500
shares of Class A Common Stock at $
11.50
per
share were issued on November 19, 2021. At March 31, 2022, no Public Warrants or Private Placement Warrants have been exercised.
The
25,287,500
shares of Class A Common Stock for which the outstanding Public Warrants and Private Placement Warrants are exercisable
were excluded from diluted earnings per share for the period ended March 31, 2022 because they are contingently exercisable, and the contingencies
have not yet been met. As a result, diluted net loss per share of common stock is the same as basic net income loss per share of common
stock for the period. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net
loss per share for each class of stock.
For the period from January 1, 2022 through March 31, 2022
Basic and diluted net loss per share:
Class A Common Stock
Class B Common Stock
Numerator:
Allocation of net loss before accretion income
$
(
254,043
)
$
(
63,511
)
Accretion for Class A Common Stock to redemption value
—
—
Net loss
(
254,043
)
(
63,511
)
Denominator:
Weighted average shares outstanding
25,875,000
6,468,750
Basic and diluted net loss per share
$
(
0.01
)
$
(
0.01
)
For the period February 19, 2021 (inception) to March 31, 2021
Basic and diluted net loss per share:
Class A Common Stock
Class B Common Stock
Numerator:
Allocation of net loss before accretion income
$
—
$
(
3,613
)
Accretion for Class A Common Stock to redemption value
—
—
Net loss
—
(
3,613
)
Denominator:
Weighted average shares outstanding
—
6,468,750
Basic and diluted net income (loss) per share
$
—
$
(
0.00
)
Warrant Instruments
The Company accounts for warrants
as either equity-classified or liability-classified instruments based on an assessment of the instruments' specific terms and applicable
authoritative guidance in ASC 480 and A
S
C 815, Derivatives and Hedging ("ASC 815").
The assessment considers whether the instruments are free standing financial instruments pursuant to
A
SC
480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classificat
i
on
under ASC 815, including whether the instruments are indexed to the Company
'
s own common
shares and whether the instrument holders could pote
n
tially require "net cash settlement"
in a circumstance outside of the Company
'
s control, among other conditions for equity
classification. This as
s
essment, which requires the use of professional judgment, was conducted
at the time of warrant issuance and as of each subsequent period end date while the instruments are outstanding. Management has concluded
that the Public
W
arrants and Private Placement Warrants issued pursuant to the war
r
ant
agreement qualify for equity accounting treatment.
11
Stock Compensation Expense
In connection with the Company's
IPO, founder's shares were sold to certain independent directors by the Sponsor at the price of $
0.0004
per share.
The Company accounts for stock-based
compensation expense in accordance with ASC 718, "Compensation – Stock Compensation" ("ASC 718") under which
stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date and recognized over the
requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a
given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized
once the event is deemed probable to occur. Forfeitures are recognized as incurred.
The fair value of the 80,000 founder
shares sold to certain independent directors as of November 9, 2021, was $627,119, or $7.84 per share.
The Company used a Monte Carlo
Model Simulation to arrive at the fair value of the stock compensation. The key assumptions in the option pricing model utilized are assumptions
related to expected separation date of Units, anticipated business combination date, purchase price, share-price volatility, expected
term, exercise date, risk-free interest rate and present value. The expected volatility as of the IPO Closing Date was derived based upon
similar SPAC warrants and technology exchange traded funds which aligns with Company's stated industry target and present value
factor was based on risk-free rate and terms until the exercise date. The Company's Founder Shares sold to independent directors
(see Note 4) were deemed within the scope of ASC 718 and are subject to a performance condition, namely the occurrence of a Business Combination.
Compensation expense related to the Founder Shares transferred is recognized only when the performance condition is probable of occurrence,
or more specifically when a Business Combination is consummated. Therefore, no stock-based compensation expense has been recognized during
the period from February 19, 2021 (inception) through March 31, 2022.
Recent Accounting Pronouncements
In August 2020, the FASB issued
Accounting Standards Update ("ASU") No. 2020-06, Debt — debt with Conversion and Other Options (Subtopic 470-20) and
Derivatives and Hedging — Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts
in an Entity's Own Equity ("ASU 2020-06"), which simplifies accounting for convertible instruments by removing major
separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked
contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas.
The Company adopted ASU 2020-06 on February 19, 2021 (inception). Adoption of the ASU did not impact the Company's financial position,
results of operations or cash flows.
The Company has reviewed other recent accounting pronouncements
and concluded that they are either not applicable to the Company, or no material effect is expected on the financial statement as a result
of future adoption.
Note 3 —
Initial Public Offering
Pursuant to the IPO, and including
the underwriter's exercise of its over-allotment option, the Company sold
25,875,000
Units at a price of $
10.00
per
Unit resulting in gross proceeds of $
258,750,000
and net proceeds of $
243,738,425
after deduction of offering costs. Each Unit
consists of one Public Share and one-half of one Public Warrant. Each Public Warrant entitles the holder to purchase one share of Class
A Common Stock at a price of $
11.50
per share, subject to adjustment (see Note 6).
Note 4 —
Related Party Transactions
Founder Shares
On March 5, 2021, the Sponsor acquired
100
shares
of the Company's common stock. On March 15, 2021, the Company effectuated a recapitalization of the Company, which included a
64,687.50-for-1
stock split
, resulting in an aggregate of 6,468,750 Founder Shares outstanding. On June 21, 2021, the Company effectuated a
recapitalization of the Company, which included a
1.11-for-1 stock split
, resulting in an aggregate of
7,187,500
Founder
Shares outstanding. On October 26, 2021, the Company effectuated a recapitalization of the Company, which included a
1-for-1.11 reverse
stock split
, resulting in an aggregate of
6,468,750
Founder Shares outstanding (up to
843,750
of which were subject
to forfeiture if the underwriter's over-allotment option was not exercised in full). Since the underwriter exercised its over-allotment
option in full, the Sponsor did not forfeit any Founder Shares. The Sponsor subsequently transferred an aggregate of
80,000
Founder
Shares to the members of the Company's board of directors for the same per-share consideration that it originally paid for such
shares, resulting in the Sponsor holding
6,388,750
Founder Shares.
The Founder Shares will automatically
convert into shares of Class A Common Stock at the time of the Company's initial Business Combination and are subject to certain
transfer restrictions. Holders of Founder Shares may also elect to convert their shares of Class B Common Stock into an equal number of
shares of Class A Common Stock, subject to adjustment, at any time.
12
The Initial Stockholders have
agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of:
(A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if
the last sale price of the Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends,
reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150
days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock
exchange or other similar transaction that results in all of the Company's stockholders having the right to exchange their
shares of common stock for cash, securities or other property.
Private Placement
On November 19, 2021, simultaneously
with the consummation of the IPO and the underwriter's exercise of its over-allotment option, the Company consummated the issuance
and sale of
12,350,000
Private Placement Warrants in a Private Placement at a price of $
1.00
per Private Placement Warrant,
generating gross proceeds of $
12,350,000
. Each Private Placement Warrant is exercisable to purchase one share of Class A Common Stock
at a price of $
11.50
per share. A portion of the proceeds from the Private Placement was added to the proceeds from the IPO being
held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the
sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable
law), and the Private Placement Warrants and all underlying securities will be worthless.
Related Party Loans
On March 5, 2021, the Sponsor agreed
to loan the Company an aggregate of up to $
300,000
to cover expenses related to the IPO pursuant to a promissory note (the "Note").
On June 18, 2021, the Sponsor amended the Note to increase the principal amount to $
600,000
. The loan was non-interest bearing and payable
on the earlier of March 31, 2022 or the completion of the IPO. A total of $
425,000
under the Note was borrowed from the Sponsor and
repaid in full from the proceeds of the Initial Public Offering not being placed in the Trust Account on November 19, 2021.
In addition, in order to finance
transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company's
officers and directors may, but are not obligated to, loan the Company funds as may be required ("Working Capital Loans").
If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account
released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the
event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the
Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing,
the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans.
The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender's
discretion, up to $
1.5
million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity
at a price of $
1.00
per warrant. The warrants would be identical to the Private Placement Warrants. As of March 31, 2022, no Working
Capital Loans were outstanding.
Support Services
Effective November 16, 2021,
the Company entered into an Administrative Support Agreement with an entity affiliated with the Sponsor for office space and administrative
support services at a monthly fee of $
15,000
.
Since the consummation of the IPO, the Company has paid, and intends to continue paying until the earlier of the consummation of the
Business Combination or the Company's liquidation, a fee of approximately $
15,000
per
month.
The Company recognized $45,000 and $0 for the three months ending March 31, 2022 and the period from February 19, 2021 (inception)
to March 31, 2021, respectively.
As of March 31, 2022, $
45,000
and
$
0
has been accrued for these services and is included in "Accounts payable and accrued expenses" in the accompanying
unaudited condensed balance sheets, respectively.
Note 5 —
Commitments and Contingencies
Registration Rights
The holders of Founder Shares,
Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration
rights (in the case of the Founder Shares, only after conversion of such shares to shares of Class A Common Stock) pursuant to a registration
rights agreement, dated November 16, 2021. These holders will be entitled to certain demand and "piggyback" registration rights.
However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities
Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear
the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriter
a
45
-day option from the date of the final prospectus relating to the IPO to purchase up to
3,375,000
additional Units
to cover over-allotments, if any, at the IPO price less underwriting fees. On November 19, 2021, the underwriter elected to fully exercise
its over-allotment option, purchasing
3,375,000
of such additional Units.
The underwriter was paid a cash
underwriting discount of $
0.20
per Unit sold in the IPO, including the Units issued in connection with the underwriter's exercise
of its over-allotment option, or $
5,175,000
in the aggregate at the closing of the IPO. In addition, the underwriter is entitled
to a deferred underwriting fee of $
0.35
per unit, or $
9,056,250
, from the closing of the IPO and the exercise of the underwriter's
over-allotment option. The deferred underwriting fees will become payable to the underwriter from the amounts held in the Trust Account
solely if the Company completes a Business Combination, subject to the terms of the underwriting agreement.
13
Note 6 —
Stockholders' Deficit
Common stock
Class
A Common Stock—
The Company is authorized to issue
100,000,000
shares of Class A Common Stock with a par value of
$
0.0001
per share. As of March 31, 2022 and December 31, 2021, there were
no
(excluding
25,875,000
shares of Class A Common Stock subject
to possible redemption) shares of Class A Common Stock issued and outstanding.
Class
B Common Stock
—
The Company is authorized to issue
10,000,000
shares of Class B Common Stock with a par value
of $
0.0001
per share. As of March 31, 2022 and December 31, 2021, there were
6,468,750
shares of Class B Common Stock issued and outstanding.
Preferred
Stock
—The Company is authorized to issue
1,000,000
shares of preferred stock with a par value of $
0.0001
per
share with such designations, voting and other rights and preferences as may be determined from time to time by the Company's board
of directors. For the period presented, there were
no
shares of preferred stock issued or outstanding.
Warrants
—As
of March 31, 2022 and December 31, 2021, the Company had
12,937,500
Public Warrants and
12,350,000
Private Placement Warrants outstanding.
The Company has determined that warrants issued in connection with its IPO in November 2021 are subject to treatment as equity. At IPO,
the Company utilized a Monte Carlo simulation model to value the Warrants. Inherent in a Monte Carlo simulation are assumptions related
to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of
its ordinary shares based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate
is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants.
The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical
rate, which the Company anticipates to remain at zero, the fair value of the Public and Private Placement warrants on IPO was $0.52/warrant.
The Public Warrants will become
exercisable 30 days after the completion of a Business Combination. No warrants will be exercisable for cash unless the Company has an
effective and current registration statement covering the shares of Class A Common Stock issuable upon exercise of the warrants and a
current prospectus relating to such shares of Class A Common Stock. Notwithstanding the foregoing, if a registration statement covering
the shares of Class A Common Stock issuable upon exercise of the Public Warrants is not effective within a specified period following
the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during
any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant
to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another
exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire
five years after the completion of a Business Combination or earlier upon redemption or liquidation.
Redemption of warrants when the price per share
of Class A Common Stock equals or exceeds $
18.00
Once the warrants become exercisable, the Company
may redeem the outstanding warrants:
●
in whole and not in part;
●
at a price of $
0.01
per warrant;
●
upon a minimum of 30 days' prior written notice of redemption, which we refer to as the "30-day redemption period" and
●
if, and only if, the last reported sale price of our Class A Common Stock for any 20 trading days within a 30-day trading period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders (the "Reference Value") equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities).
The Company will not redeem the
warrants as described above unless an effective registration statement under the Securities Act covering the Class A Common Stock issuable
upon exercise of the warrants is effective and a current prospectus relating to those Class A Common Stock is available throughout the
30-day redemption period. If and when the warrants become redeemable by us, we may exercise our redemption right even if the Company is
unable to register or qualify the underlying securities for sale under all applicable state securities laws.
Redemption of warrants when the price per Class
A Common Stock equals or exceeds $
10.00
14
Once the warrants become exercisable, the Company
may redeem the outstanding warrants:
●
in whole and not in part
●
at $0.10 per warrant upon a minimum of 30 days' prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth in the warrant agreement, subject to certain exceptions; and
●
if, and only if, the Reference Value of the Company's Class A Common Stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities).
The "fair market value"
of the Company's Class A Common Stock for the above purpose means the volume weighted average price of our Class A Common Stock
during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. The Company
will provide its warrant holders with the final fair market value no later than one business day after the 10-trading day period described
above ends. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A Common Stock per warrant (subject to adjustment). Any redemption of the warrants for Class A Common Stock will apply to both the Public Warrants
and the Private Placement Warrants.
No fractional Class A Common Stock
will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company
will round down to the nearest whole number of the number of Class A Common Stock to be issued to the holder. Please see the section entitled
"Description of Securities—Warrants—Public Stockholders' Warrants" for additional information.
If the Company calls the Public
Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on
a "cashless basis," as described in the warrant agreement.
The Private Placement Warrants
will be identical to the Public Warrants underlying the Units being sold in the IPO, except that the Private Placement Warrants and the
shares of Class A Common Stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable
until after the completion of a Business Combination, subject to certain limited exceptions.
The exercise price and number of
shares of Class A Common Stock issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of
a stock dividend, extraordinary dividend or our recapitalization, reorganization, merger or consolidation. However, the warrants will
not be adjusted for issuances of shares of Class A Common Stock at a price below their respective exercise prices. Additionally, in no
event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within
the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such
funds with respect to their warrants, nor will they receive any distribution from the Company's assets held outside of the Trust
Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
In addition, if the Company issues
additional shares of Class A Common Stock or equity-linked securities for capital raising purposes in connection with the closing of a
Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A Common Stock (with such issue
price or effective issue price to be determined in good faith by the Company's board of directors, and in the case of any such issuance
to the initial stockholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance),
(y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available
for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the
volume weighted average trading price of the Company's Class A Common Stock during the 10 trading day period starting on the trading
day prior to the day on which the Company consummates a Business Combination (such price, the "Market Value") is below $9.20
per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market
Value or (ii) the price at which the Company issues the additional shares of Class A Common Stock or equity-linked securities.
Note 7 —
Fair Value Measurements
The fair value of the Company's
financial assets and liabilities reflects management's estimate of amounts that the Company would have received in connection with
the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants
at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the
use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
15
Level 1: Quoted prices in active markets for identical
assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with
sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2: Observable inputs other than Level 1 inputs.
Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets
or liabilities in markets that are not active.
Level 3: Unobservable inputs based on the Company's
assessment of the assumptions that market participants would use in pricing the asset or liability.
At
March 31, 2022 and December 31, 2021, the assets held in the Trust Account were held in U.S. treasury funds. All of the
Company's investments held in the Trust Account are classified as trading securities.
The following table presents information
about the Company's liabilities that are measured at fair value on a recurring basis at March 31, 2022
and
December 31, 2021
and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
March 31, 2022
Quoted Prices in
Significant Other
Significant Other
Active Markets
Observable Inputs
Unobservable Inputs
Level
(Level 1)
(Level 2)
(Level 3)
Assets:
Cash, and U.S. Treasury Securities
1
$
264,079,072
—
—
December 31, 2021
Quoted Prices in
Significant Other
Significant Other
Active Markets
Observable Inputs
Unobservable Inputs
Level
(Level 1)
(Level 2)
(Level 3)
Assets:
Cash, and U.S. Treasury Securities
1
$
263,937,611
—
—
Note 8 —
Subsequent Events
The Company evaluated subsequent events and transactions
that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued.
On
April 13, 2022, the Sponsor issued a convertible promissory note (the "Promissory Note"), pursuant to which the Company may
borrow up to an aggregate principal amount of $1,500,000
. The Promissory Note is non-interest bearing and payable on the earlier
of (i) February 19, 2023; provided that, if and to the extent the Company exercises its right pursuant to that certain Investment Management
Trust Agreement, dated as of November 16, 2021, between the Company and Continental Stock Transfer & Trust Company, to extend the
above-referenced date of February 19, 2023 by up to six additional months, then the last day of such extended period; and (ii) the effective
date of the Business Combination (such earlier date, the "Maturity Date").
At the option of the Sponsor, at any time on or prior
to the Maturity Date, any amounts outstanding under the Promissory Note (or any portion thereof) up to $1,500,000 in the aggregate, may
be converted into warrants to purchase Class A Common Stock of the Company at a conversion price (the "Conversion Price")
equal to $1.00 per whole warrant.
As of May 11, 2022, there is an amount outstanding of $250,000
under the Promissory Note.
16
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Item 2. Management's Discussion and Analysis of Financial Condition
and Results of Operations.
References to "we," "us,"
"Company" or "our Company" refer to LF Capital Acquisition Corp. II. The following discussion and analysis of
the Company's financial condition and results of operations should be read in conjunction with the financial statements and the
notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes
forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended (the "Exchange Act"). When used in this Form 10-Q, words such as "anticipate," "believe,"
"estimate," "expect," "intend" and similar expressions, as they relate to us or the Company's
management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions
made by, and information currently available to, the Company's management. Actual results could differ materially from those contemplated
by the forward-looking statements as a result of certain factors detailed in our other filings with the SEC. Our actual results may differ
materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under "Part
II
—
Other Information. Item 1a. Risk Factors" and elsewhere in this Quarterly Report on Form 10-Q.
17
Overview
We are an early-stage blank check company incorporated
in February 2021 as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition,
stock purchase, reorganization or similar business combination with one or more businesses. We completed our IPO on November 19, 2021.
We intend to effectuate our initial business combination using cash from the proceeds of the IPO and the sale of the private placement
warrants, our capital stock, debt or a combination of cash, stock and debt.
Since
completing our IPO, we have reviewed, and continue to review, a number of opportunities to enter into an initial business combination
with an operating business, but we are not able to determine at this time whether we will complete an initial business combination with
any of the target businesses that we have reviewed or with any other target business. We presently have no revenue, have had losses since
inception from incurring formation costs and have had no operations other than the active solicitation of a target business with which
to complete an initial business combination.
We expect to continue to incur significant costs in the pursuit of our acquisition
plans. We cannot assure you that our plans to raise capital or to complete our initial business combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated
any revenues to date. Our only activities through March 31, 2022 were organizational activities, those necessary to prepare for the IPO,
described below, and, after our IPO, identifying a target company for an initial business combination. We do not expect to generate any
operating revenues until after the completion of our initial business combination. We generate non-operating income in the form of interest
income on marketable securities held in the trust account. We incur expenses as a result of being a public company (for legal, financial
reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended March 31, 2022, we
had a net loss of $317,554, which consisted of operating costs of $373,271, offset by an unrealized gain on marketable securities
held in the trust account of $141,460.
Liquidity and Capital Resources
As of March 31, 2022, the Company had $71,604 in
its operating bank account, $264,079,072 in securities held in the Trust Account to be used for a Business Combination or to repurchase
or redeem its common stock in connection therewith and working capital of $264,991.
Prior to the completion of the IPO, the Company's
liquidity needs were satisfied through the payment of $25,000 from the Sponsor to cover certain offering costs on the Company's
behalf in exchange for issuance of Founder Shares and a promissory note, as amended, from the Sponsor for a total of $425,000. The promissory
note from the Sponsor was paid in full on November 19, 2021. Subsequent to the IPO, the Company's liquidity needs have been satisfied
through a portion of the net proceeds from the Private Placement.
In addition, in order to finance transaction
costs in connection with a Business Combination, the Company will need to raise additional capital through loans or additional
investments from its Sponsor, shareholders, officers, directors, or third parties. The Company's officers, directors and
Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem
reasonable in their sole discretion, to meet the Company's working capital needs. As of March 31, 2022, there were no amounts
outstanding under any Working Capital Loans. Subsequent to March 31, 2022, the Company obtained a loan from its Sponsor.
Please see the section entitled "Recent Developments" for additional information.
Based on the foregoing, management believes that the
Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business
Combination or one year from the date of this filing.
Off-Balance Sheet Arrangements
As of March 31, 2022, we had no obligations, assets
or liabilities, which would be considered o
f
f-balance sheet arrangements.
Contractual Obligations
As of March 31, 2022, we do not have any long-term
debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay affiliate of our
Sponsor a monthly fee of $15,000 for office space, utilities and secretarial and administrative and support. We began incurring these
fees on consummation of the IPO and will continue to incur these fees monthly until the earlier of the completion of our initial business
combination and our liquidation.
18
The underwriter is entitled to a deferred fee of $0.35 per
unit sold in the IPO, or $9,056,250 in the aggregate. This deferred fee will be waived by the underwriter in the event that the Company
does not complete an initial business combination, subject to the terms of the underwriting agreement with respect to the Company's
IPO.
Critical Accounting Policies and Estimates
The preparation of the unaudited condensed financial
statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets
and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and income
and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following
as our critical accounting policies:
Class A Common Stock Subject to Possible Redemption
W
e account
for our
Class A
Common Stock subject to possible redemption in accordance with the guidance
in Accounting Standards Codific
a
tion ("ASC")
T
opic
480 "Distinguishing Liabilities from Equit
y
." Common stock subject to mandatory
redemption is classified as a liability
i
nstrument and is measured at fair value. Conditionally
redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject
to redemption upon the occurrence of uncertain events not solely within our control) is class
i
fied
as temporary equit
y
. At all other times, common stock is classified as stockholders'
equit
y
. Our
Class A
Common Stock features certain
redemption rights that
a
re considered to be outside of our control and subject to occurrence
of uncertain future events. Accordingl
y
,
our Class A
Common
Stock subject to possible red
e
mption is presented as temporary equit
y
,
outside of the stockholders' equity section of our balance sheets. The Company recognizes changes
i
n
redemption value immediately as they occur and adjusts the carrying value of redeemable
Class A
Common
Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable
Class
A
Common Stock are a
f
fected by cha
r
ges
against additional paid in ca
p
ital and accumulated deficit.
Net Loss Per Ordinary Share
Net loss per share is computed by dividing net loss
by the weighted average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture
by the Sponso
r
.
The calculation of diluted loss per share
does not consider the effect of the warrants issued in connection with the IPO and warrants issued in the Private Placement since the
exercise of these warrants are contingent upon the occurrence of future events. For the three months ended
March 31, 2022, the
Company did not have any dilutive securities and/or other contracts that could, potentiall
y
,
be exercised or converted into shares of comm
o
n stock and then share in the earnings of the
Compan
y
. As a result, diluted loss per share is the same as basic loss per share for the period
presented.
Recent Accounting Standards
The Company has reviewed recent accounting pronouncements
and concluded that they are either not applicable to the Company or no material effect is expected on the unaudited condensed financial
statements as a result of future adoption.
Recent Developments
On
April 13, 2022, the Sponsor issued a Promissory Note, pursuant to which the Company may borrow up to an aggregate principal amount of
$1,500,000
. The Promissory Note is non-interest bearing and payable on the Maturity Date.
At the option of the Sponsor, at any time on or prior
to the Maturity Date, any amounts outstanding under the Promissory Note (or any portion thereof) up to $1,500,000 in the aggregate, may
be converted into warrants to purchase Class A Common Stock of the Company at the Conversion Price.
As
of May 11, 2022, there is an amount outstanding of $250,000 under the Promissory Note.
Item 3. Quantitative and Qualitative Disclosures
About Market Risk
We are a smaller reporting company as defined in Rule
12b-2 under the Exchange Act. As a result, pursuant to Item 305(e) of Regulation S-K, we are not required to provide the information required
by this Item.
Item 4. Controls and Procedures
Disclosure controls are procedures that are designed
with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Quarterly
Report on Form 10-Q, is recorded, processed, summarized, and reported within the time period specified in the SEC's rules and forms.
Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management,
including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.
19
Our management evaluated, with the participation of
our current chief executive officer and chief financial officer (our "Certifying Officers"), the effectiveness of our disclosure
controls and procedures as of March 31, 2022, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our
Certifying Officers concluded that, as of March 31, 2022, our disclosure controls and procedures were effective.
Changes in Internal Control Over Financial Reporting
During the quarter ended March 31, 2022, there has
been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect,
our internal control over financial reporting.
PART II—OTHER INFORMATION
Item 1. Legal Proceedings.
None.
Item 1a. Risk Factors.
Factors that could cause our actual results to differ
materially from those in this Quarterly Report are any of the risks described in our Annual Report on Form 10-K filed with the SEC on
March 25, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial
condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results
of operations.
As of the date of this Quarterly Report on Form 10-Q,
there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC on March 25, 2022.
However, we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.
Unregistered Sales of Equity Securities
On March 5, 2021, our Sponsor acquired 100 shares
of the Company's common stock in exchange for a capital contribution of $25,000, or approximately $250.00 per share, in a private
placement. The acquisition of such shares was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities
Act. On March 15, 2021, we effected a 64,687.5-for-one forward stock split of our issued and outstanding shares of common stock and reclassified
those issued and outstanding shares into shares of Class B Common Stock. On June 21, 2021, we effected an approximately 1.11-for-one forward
stock split of our issued and outstanding shares of Class B Common Stock. On October 26, 2021, we effected an approximately one-for-1.11
reverse stock split of our issued and outstanding shares of Class B Common Stock. At the time of our IPO, the Sponsor held 6,468,750 founder
shares (reflecting an aggregate capital contribution of approximately $0.004 per share). The number of founder shares issued was determined
based on the expectation that such founder shares would represent 20% of the issued and outstanding shares of our common stock upon completion
of the IPO. On November 19, 2021, our Sponsor transferred 20,000 founder shares to each of our independent directors at their original
purchase price in a private placement. This issuance was made pursuant to the exemption from registration contained in Section 4(a)(2)
of the Securities Act. In addition, at the closing of our initial business combination, our anchor investor will be entitled to purchase
from our Sponsor an aggregate of 12.5% of the number of founder shares outstanding upon the final closing of the IPO, at a purchase price
of approximately $0.004 per share.
Use of Proceeds
On November 19, 2021, the Company consummated its
IPO of 25,875,000 units, including 3,375,000 units issued pursuant to the full exercise of the underwriter's over-allotment option.
Each unit consists of one share of Class A Common Stock and one-half of one redeemable warrant of the Company, with each whole warrant
entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share. The units were sold at a price of $10.00
per unit, generating gross proceeds to the Company of $258,750,000.
A total of $263,925,000 of the proceeds from the IPO
(which amount includes $9,056,250 of the underwriter's deferred fee) and the sale of the Private Placement Warrants, was placed
in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as
trustee. The proceeds held in the trust account may be invested by the trustee only in U.S. government securities with a maturity of 185
days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule
2a-7 under the Investment Company Act of 1940, as amended.
Item 3. Defaults Upon Senior Securities.
None.
20
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
None.
Item 6. Exhibits.
The following exhibits are filed as part of, or incorporated
by reference into, this Quarterly Report.
No.
Description of Exhibit
31.1
Certification of the Principal Executive Officer required by Rule 13a-14(a) or Rule 15(d)-14(a)
31.2
Certification of the Principal Financial Officer required by Rule 13a-14(a) or Rule 15(d)-14(a)
32.1
Certification of the Principal Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350
32.2
Certification of the Principal Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350
21
SIGNATURES
Pursuant to the requirements of Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
LF Capital Acquisition Corp. II
Date: May 11, 2022
/s/ Scott Reed
Name:
Scott Reed
Title:
President, Chief Executive Officer
22